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ABSTRACT  
Clostridium difficile is an obligate anaerobic, Gram-positive, endospore-forming bacterium. 
Although an opportunistic pathogen, it is one of the important causes of healthcare-associated 
infections. C. difficile colonizes the gut when the normal intestinal microflora is disrupted by 
antimicrobial agents and causes Clostridium difficile infection (CDI). Recurrent clostridial 
infections and rapid rise of antibiotic resistant strains have made disease treatment very 
difficult.  
While toxins TcdA and TcdB are the main virulence factors of C. difficile, the factors or 
processes involved in gut colonization during infection remain unclear. The biofilm-forming 
ability of bacterial pathogens has been associated with increased antibiotic resistance and 
chronic recurrent infections. Bacteria within biofilms, which are complex bacterial 
communities held together by a self-produced extracellular matrix, are protected from 
multiple stresses, including immune responses and antimicrobial agents. Although biofilms 
have been well studied for several gut pathogens, little is known about biofilm formation by 
anaerobic gut species. Biofilm formation by C. difficile could play a role in virulence and 
persistence of C. difficile, as seen for other intestinal pathogens. This work aimed to study 
biofilm formation by C. difficile and the factors that modulate this process.  
We demonstrate that C. difficile clinical strains, 630, and the strain isolated in the outbreak, 
R20291, form structured biofilms in vitro. Biofilm matrix is made of proteins, DNA and 
polysaccharide. Strain R20291 accumulates substantially more biofilm. Employing isogenic 
mutants, we show that virulence-associated proteins, Cwp84, flagella and a putative quorum 
sensing regulator, LuxS, are required for maximal biofilm formation by C. difficile. A mutant 
in Spo0A, a transcription factor that controls spore formation, was also defective for biofilm 
formation, indicating a possible link between sporulation and biofilm formation. Moreover we 
demonstrate that bacteria in C. difficile biofilms are more resistant to high concentrations of 
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vancomycin, a drug commonly used for treatment of CDI, and that inhibitory and sub-
inhibitory concentrations of the same antibiotic induce biofilm formation.  
Surprisingly, clinical C. difficile strains from the same out-break, but from different origin, 
show differences in biofilm formation. Genome sequence analysis of these strains showed 
presence of a single nucleoide polymorphism (SNP) in the anti-σ factor RsbW, which 
regulates the stress-induced alternative sigma factor B (σB). We further demonstrate that 
RsbW, a negative regulator of alternative sigma factor B, has a role in biofilm formation and 
sporulation of C. difficile.  
Our data suggest that biofilm formation by C. difficile is a complex multifactorial process and 
may be a crucial mechanism for clostridial persistence in the host. 
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1 INTRODUCTION  
1.1 Clostridium difficile 
Clostridium difficile is a Gram positive, rod shaped, obligate anaerobic bacterium. C. difficile 
belongs to the phylum Firmicutes, and like other genera from this phylum, exists in two forms, 
the vegetative cell and in the endospore (Figure 1) (Fritze, 2004). When in the vegetative form 
the bacterium is metabolically active and in a reproductive state, while when in the endospore 
form, the bacterium is a metabolically dormant, non-reproductive state. As an endospore, the 
bacterium can survive for long periods under unfavourable conditions, like lack of nutrients, 
severe physical and chemical environments, and extreme temperatures (Setlow, 2007).  
 
 
Figure 1 C. difficile spore and vegetative cell (Vedantam et al., 2012). 
 
Clostridium difficile is an intestinal opportunistic pathogen of humans and animals and in the 
last decades was recognized as the most common cause of nosocomial diarrhea (Poxton et al., 
2001); (Rupnik et al., 2009); (Kuipers and Surawicz, 2008). C. difficile infections (CDI) occur 
when the normal intestinal flora is damaged or absent after the use of antimicrobial agents. 
The bacterium colonizes the last part of the intestinal tract, the colon. Clinical outcomes can 
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range from asymptomatical colonization or mild diarrhoea to severe disorders, such as 
pseudomembranous colitis (PMC) (Rupnik et al., 2009). Antibiotic treatment is available, but 
high percentages of patients develop recurrent infections. The spores were connected with the 
transmission and the recurrence of the disease (Lawley et al., 2009); (Vedantam et al., 2012). 
 
1.1.1 History 
C. difficile was first reported in first half of the last century. In 1935, in an attempt to 
understand the development of normal bacterial flora in neonates, Hall and O'Toole (1935) 
discovered a new pathogenic anaerobe, which they named Bacillus difficilis. The name 
'difficilis' (Latin 'difficile' stands for 'difficult, obstinate') was given to the newly isolated 
bacterium because of the difficulty involved in its isolation and study. Bacillus difficilis, later 
renamed in Clostridium difficile and placed in the genus Clostridium, did not show 
pathogenicity in newborns, but was pathogenic in guinea pigs.  
The connection between C. difficile infections, and diseases caused by it, was first reported 
long after the first isolation. While the disease pseudomembranous colitis (PMC) was first 
described by Finney in 1893, the connection with the Clostridium difficile was not linked till 
second half of 20
th
 century. In 1974 Tedesco et al. (Tedesco et al., 1974) published the key 
paper connecting the use of antibiotics to PMC (at the time named 'clindamycin-associated 
colitis', due to the connection of use of antibiotics with the development of the disease), and 
couple of years later, C. difficile was found responsible for causing the disease (Gerding, 
2009). 
Since then the bacterium Clostridium difficile has been well studied and characterized. Two 
large toxins, toxin A and toxin B, were recognized as main virulence factors (Kuehne et al., 
2010); (Lyras et al., 2009); (Shen, 2012); (Voth and Ballard, 2005). However, of late, due to 
high percentage of recurrent and persistent infections, other virulence factors like colonization 
and spore formation, are coming to the forefront. 
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1.1.2 Clostridium difficile infection (CDI) 
Clostridium difficile infection (CDI) is recognized as one of the main causes for healthcare 
associated diarrheoa in recent years. Elderly patients, undergoing treatment with broad-
spectrum antibiotics or surgical procedures, in the hospitals or other healthcare institutions, 
are at the highest risk for developing CDI (Figure 2) (Rupnik et al., 2009). The symptoms of 
the infection can be mild, where the patients may present slight fever, loose stools and 
abdominal cramps. The disease can progress to severe colitis with typical adherent 
pseudomembranes, which can coalesce to obscure the mucosa. Severe colitis can result in 
toxic megacolon, colon perforation and progressive multiorgan failure. Mortality in patients 
with CDI ranges from 8–38% (Mitchell and Gardner, 2012). 
Clostridium difficile, as an obligate anaerobic bacterium, can exist in aerobic conditions 
exclusively in the form of spores. As such, it is present in the air and on contaminated medical 
devices. Hence, the only way that C. difficile can infect the host, is in the form of spores. The 
most common way of transmission of C. difficile spores is by direct contact between patients, 
through the contact between healthcare workers and patients, or via contact with contaminated 
surfaces. Most people acquire the infection once hospitalized, or in other healthcare 
institutions. However, infections acquired in the community have started to increase. C. 
difficile spores are high resistant to different stresses like heat stress, low pH stress, presence 
of alcohol or other disinfectants. This allows C. difficile spores to persist in the hospital and 
healthcare environments for months. Around 3% of healthy adults, and about 20 % of treated 
patients, carry C. difficile, and it is known, that both, asymptotic carriers and infected patients, 
are sources of infection (Gould and McDonald, 2008). 
Recurrences of disease are frequent and pose major problems for the clinical treatment of CDI. 
Recurrent CDI can arise in 20% of the cases after the first episode, and in 50% after the 
second episode after the treatment (Barbut et al., 2007). 
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Figure 2 Hospitalized patients are at the highest risk for developing CDI. Patients come in contact with C. 
difficile spores when hospitalized and through the contact with the hospital environment or health care workers. 
If the acquired C. difficile strain is a toxigenic strain, and the patient after taking antibiotics fails to mount an 
anamnestic serum immunoglobulin G (IgG) antibody response to toxin A (TcdA), the patient develops CDI. In 
case, when the patient can mount an antibody response, or if the acquired C. difficile strain is a non-toxigenic 
strain, the colonization with C. difficile is asymptomatic. It has been shown that colonized patients develop  
protection from CDI (Rupnik et al., 2009). 
 
1.1.2.1 Emergence of ‘hypervirulent’ strains   
The rates and the severity of CDI is drastically increasing since 2000. The parts of the world 
where the CDI causes biggest problems are the developed countries, where the antibiotic 
treatments are most common, like in North America and big part of Europe. The increasing 
incidence and severity of CDI has been attributed to the emergence of ribotype 027 
(McDonald et al., 2005); (Loo et al., 2005); (O'Connor et al., 2009); (Warny et al., 2005). The 
factor thought to contribute to incidence is the strain's resistance to fluoroquinolones, and 
enhanced virulence, which was associated with increased toxin production in vitro (Warny et 
al., 2005). Emerging strains belonging to PCR-ribotype 017 and 078, that are also linked with 
severe disease, have been isolated in parts of Asia and Europe (Drudy et al., 2007); (Kim et al., 
2008). At the moment there is a prevalent interest in understanding the underlying factors that 
have led to the emergence and the apparent increased virulence of such C. difficile strains. 
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1.1.2.2 Transmition and colonization of the colon  
Since the spores are resistant to the low pH, they can pass through the stomach acid 
environment, and reach the small intestine. Favourable conditions of the small intestine 
(presence of specific germination-promoting factors e.g. bile salts) promote spore germination 
(Burns, 2010). Vegetative bacteria can then colonize the last part of the intestinal tract, the 
colon. Colonization can occur only when the normal intestinal microflora of the host is absent 
or altered, which usually occurs in the presence of risk factors, such as prolonged antibiotic 
therapy, advanced age, or hospitalization (Poxton et al., 2001); (Rupnik et al., 2009); (Kuipers 
and Surawicz, 2008). Thus, a strong association between antimicrobial therapy and CDI has 
been almost generally recognized. Once the bacteria proliferate in the colon of the host, they 
are able to produce toxins, which results in the characteristic pathology of the colon (Figure 3) 
(Vedantam et al., 2012).  
 
Figure 3 Schematic of human C. difficile infection. Bacterial factors that contribute to the colonization of the 
human intestine are spores, vegetative cells, tolerance to the bile salts, cell-wall proteins resistance to 
cathelicidin and O-nitrosylation. Resistant barrier mechanisms from the side of the host are gastric acid, bile salts, 
innate and adaptive immune responses and normal gut microbiota (Vedantam et al., 2012). 
 
Initial studies correlating antibiotic treatment and CDI were focused on use of antibiotics 
clindamycin and cephalosporins (Aronsson et al., 1985); (Gerding, 2009). Subsequently the 
use of fluoroquinolones have arisen as possibly the major inducing agents. Use of 
fluoroquinolones was connected with several outbreaks of the CDI (Pepin et al., 2005). The 
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only way to control the emerging outbreaks has been to restrain, or completely prohibit, the 
use of the entire class of these antibiotics (Gerding, 2004); (Kallen et al., 2009).  
 
1.1.2.3 Recurrence and the treatment of CDI   
Recurrence and severe complications of CDI are the main problems in the treatment of CDI. 
Antibiotics of choice for the treatment of CDI are metronidazole and vancomycin. Resistance 
to antibiotics used for treatment  does not pose a significant threat so far. Nonetheless, in the 
case of multiple recurrences, the CDI typically respond to treatment with vancomycin or 
metronidazole, but the diarrheoa symptoms resume within days to weeks after treatment is 
stopped. Between 20% and 50% of these recurrences are caused by a reinfection rather than a 
relapse of the original infection (Johnson et al., 1989); (O'Neill et al., 1991). Till recently no 
highly effective treatment for multiple recurrent CDI have been recognise as efficient. 
Prolonged pulse dosing of vancomycin was used in hope of preventing C. difficile from 
regrowth, while the normal microflora recovers. Lately was demonstrated that treatment with 
antibiotic fidamoxin is not inferior compared to current available antibiotics, but has minimal 
effect on the normal colonic microflora, which is the reason why less patients develop a 
recurrent CDI (Cornely, 2012). Moreover treatment with the replacement of the normal 
bacterial flora with a faecal transplant, delivered either by nasogastric tube or by enema, 
shown to be very effective (Aas et al., 2003); (Di Bella et al., 2013). In cases of severe 
complicated CDI no highly effective cure has been found and in some cases surgical removal 
of the colon can be the only remaining life-saving treatment (Lamontagne et al., 2007). Novel 
methods and agents, for the treatment of multiple relapsing and complicated CDIs, are needed. 
Several approaches are under investigation, including vaccine development, toxin-binding 
agents and passive antibodies.  
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1.1.3 Virulence factors 
The majority of Clostridium difficile strains, associated with CDI  are toxigenic strains. This 
made two large clostridial toxins, toxin A and toxin B (TcdA and TcdB), the best studied C. 
difficile virulent factors (Kuehne et al., 2010); (Lyras et al., 2009); (Voth and Ballard, 2005); 
(Schwan et al., 2009). However, other virulence factors are needed during the pathogenesis 
for other steps e.g. adaptation to the host, adhesion to the gut mucosa, colonization and 
dissemination. Lack of available molecular tools for C. difficile made studies on clostidial 
pathogenesis more complicated (Kuehne et al., 2011). In recent years the available sequence 
for several C. difficile genomes (Sebaihia et al., 2006); (He et al., 2013), and the development 
of molecular tools that allow C. difficile genetic studies (Cartman et al., 2012); (Kuehne et al., 
2011), have led to a increase in knowledge of the molecular basis of C. difficile pathogenesis 
and non-toxin virulence factors involved in the CDI. Yet, still very little is known about non-
toxin virulence factors and their role in pathogenesis.   
 
1.1.3.1 Toxins  
1.1.3.1.1 Toxin A and toxin B  
Two main toxins, produced by C. difficile, are toxin A (TcdB) and toxin B (TcdB) (Voth and 
Ballard, 2005). TcdA and TcdB cause symptoms of the disease, triggering intestinal damage, 
and the release of nutrients from the damaged colonic epithelium. TcdA and TcdB target the 
Ras superfamily of GTPases, modifying glycosylation, and ultimately leading to the 
destruction of intestinal epithelial cells (Carter et al., 2012); (Voth and Ballard, 2005). 
 
Toxins are encoded in the Pathogenicity Locus (PaLoc) (Figure 4a), which is approximately 
19.6 kb big and is very stable and conserved among toxigenic strains (Cohen et al., 2000); 
(Voth and Ballard, 2005). Nontoxigenic strains lack the PaLoc, but isolates with a defective 
PaLoc can still colonize the gut (Cohen et al., 2000); (Curry et al., 2007).  
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PaLoc carries five genes: tcdA, tcdB, tcdC, tcdE and tcdR. The two toxin genes, tcdA and tcdB, 
are closely aligned, separated by an intervening sequence (tcdE) (Voth and Ballard, 2005).  
The proposed function for a tcdE, which encodes a holin, a protein with pore-forming activity, 
is to allow the release of TcdA and TcdB from the cell. Recently however, it was shown that 
TcdE does not exhibit pore-forming function in C. difficile (Olling et al., 2012); (Voth and 
Ballard, 2005).  
TcdR, found upstream of tcdB, is a major positive regulator of toxin expression. TcdR 
responds to the environmental conditions, and increases during the stationary phase (Voth and 
Ballard, 2005). TcdC, found downstream of tcdA, has been long time considered a negative 
regulator of toxin production, but a recent report showed that functionality of this gene does 
not affect toxin production (Cartman et al., 2012).  
All the genes of the locus, except tcdC, are expressed during stationary phase. Additionally, 
the expression of the toxin genes has been shown to be regulated by the global gene regulator 
CodY, which acts by monitoring environmental nutrient factors (Dineen et al., 2007). In the 
presence of sufficient nutrients, CodY binds to the promoter region of tcdR, and represses 
toxin gene expression. When nutrients in the environment are lacking, toxin gene expression 
is de-repressed (Voth and Ballard, 2005); (Carter et al., 2012); (Dineen et al., 2007). 
 
TcdA and TcdB are part of the large clostridial toxin family, along with Clostridium sordellii 
lethal and hemorrhagic toxin, and Clostridium novyi alpha toxin (Carter et al., 2012). Both 
toxins, TcdA and TcdB, are glucosyltransferases. They transfer a UDP-glucose to small 
GTPases, such as Rho, Rac, and Cdc42, in the host cell. These small proteins are important in 
regulating signalling pathways. Glycosylation disrupts these pathways, which results in 
morphological changes of the cell, inhibition of cell division and membrane trafficking, and 
eventually cell death (Dawson et al., 2009); (Voth and Ballard, 2005).  
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Toxins A and B are large single-stranded proteins. Recent X-ray crystallography and small 
angle X-ray scattering models (SAXS) of TcdB suggested four structural domains (Figure 4a) 
(Albesa-Jove et al., 2010), including: (i) a biologically active N-terminal glucosyltransferase 
protruding from the core of the protein; (ii) a cysteine protease domain; (iii) a middle 
translocation section that contains a hydrophobic region implicated in toxin delivery; and (iv) 
a C-terminal receptor-binding domain (Albesa-Jove et al., 2010).  
Toxin activity is located in the N-terminal domain. This portion is delivered into the cytosol 
of host cells (Jank and Aktories, 2008). Cleavage of the biologically active segment occurs by 
autoproteolysis via the cysteine protease domain (Albesa-Jove et al., 2010).  
The C-terminal domain has short combined repetitive oligopeptides (CROPs) for receptor 
binding. In animal models of TcdA, carbohydrate structures play a role in toxin binding 
(Rupnik et al., 2009); (Voth and Ballard, 2005). These carbohydrates are not present in 
humans and the glycoprotein gp96 present in the human colon is the receptor for TcdA 
(Rupnik et al., 2009).  
 
Toxin A binds to the apical side of the cell. After the internalization in the cell, TcdA, causes 
cytoskeletal changes, what results in disruption of tight junctions and loosening of the 
epithelial barrier. This causes the cell death or the production of inflammatory mediators, 
which subsequently attract neutrophils. With the disruption of tight junctions toxins TcdA and 
TcdB are now able to cross the epithelium. Unlike TcdA, TcdB binds to the basolateral part of 
membrane.  
Presence of the two cytotoxic toxins causes inflammation and accumulation of neutrophils as 
a result to the induced response of various immunomodulatory mediators from epithelial cells, 
phagocytes and mast cells (Figure 5) (Rupnik et al., 2009).  
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Figure 4 Toxin A and toxin B, produced by C. difficile.  (A) The pathogenicity locus (PaLoc) encodes two 
large toxins, toxin A and toxin B (TcdA and TcdB), together with other three genes. Toxins are single-chain 
proteins with several functional domains and motifs. TcdB is shown in detail below the PaLoc. (B) The binary 
toxin or Cdt (C. difficile transferase), is encoded on a separate region of the chromosome (CdtLoc), and 
comprises three genes. The binary toxin is composed of two unlinked proteins, CdtB and CdtA. CdtB has a 
binding function and CdtA is the enzymatic component (Carroll and Bartlett, 2011). 
 
The importance of two toxins in the clostrial pathogenesis has been long under question. First 
reports indicated that TcdA (308 kDa), an enterotoxin, was toxin associated with disease, and 
therefore necessary for virulence. This hypothesis was rejected when TcdA− TcdB+ strains 
were associated with outbreaks of severe C. difficile infection (Freeman et al., 2010). A report 
by Lyras et al. showed that TcdB (270 kDa), a cytotoxin, is 100- to 1000-fold more toxic to 
culture cells than TcdA, and that TcdB, and not TcdA, essential for clostridial virulence 
(Lyras et al., 2009). However, Kuehne et al. re-established the observation that both toxins 
can cause significant disease (Kuehne et al., 2010). In that study TcdA+ TcdB− isolates were 
as likely to cause disease as the wild-type strains. 
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Figure 5 Clostridium difficile pathogenesis. After disruption of the normal intestinal flora C. difficile can 
colonizes the last part of intestine, the colon. Bacterial cells are presented as free and attached cells (red). TcdA 
(blue) binds to the apical side of the cell and can internalize in the cell, causing cytoskeletal changes, which 
results in disruption of tight junctions and loosening of the epithelial barrier, cell death or in the production of 
inflammatory mediators that attract neutrophils. Disruption of tight junctions enables toxins to cross the 
epithelium. TcdB (pink) binds preferentially to the basolateral cell membrane. Toxins are cytotoxic and induce 
the release of various immunomodulatory mediators from epithelial cells, phagocytes and mast cells, resulting in 
inflammation and the accumulation of neutrophils (Rupnik et al., 2009). 
 
1.1.3.1.2 C. difficile Transferase (binary toxin Cdt)  
C. difficile transferase (Cdt), also known as binary toxin, is encoded on the Cdt locus (CdtLoc) 
(Figure 4b), and it is found in approximately 6%–12.5% of all C. difficile strains (Schwan et 
al., 2009); (Sundriyal et al., 2010). While the role of the toxins TcdA and TcdB in disease has 
been extensively studied, the role of the binary toxin is less certain and many information are 
still missing. 
Cdt is an ADP-ribosylating toxin that disrupts the cytoskeleton of the cell, leading to 
excessive fluid loss, rounding of the cell, and eventual cell death (Sundriyal et al., 2010). Cdt 
is composed of two subunits, CdtA and CdtB (Figure 4b). Each component alone is not 
cytotoxic, while together they cause cytotoxicity in vitro. The fact that the incidence of Cdt is 
INTRODUCTION 
 
12 
 
higher in some strains isolated from the outbreaks, suggests that Cdt contributes to the 
severity of disease (Sundriyal et al., 2010); (Geric et al., 2006).  
Cdt induces the formation of novel thin, dynamic, microtubules on the surface of epithelial 
cells, leading to increased adherence of bacteria in vitro and in vivo (Schwan et al., 2009). 
Electron microscopy showed that these protrusions increase adherence to the epithelial cell 
surface approximately five-fold in vitro and four-fold in the mouse large intestine, indicating 
an important role for Cdt in intestinal colonization (Schwan et al., 2009). 
 
1.1.3.2  Sporulation  
C. difficile spores are highly resistant, metabolically inactive, dormant cells. When bacteria 
exist as spores they can survive in the environments where heat, chemical stress and pH 
extremes are present. Spores are moreover resistant to mechanical forces and aerobic 
conditions (Borriello et al., 1990). Because of their morphological and physiological 
characteristics, spores can persist on hospital surfaces and in the air, where they can then 
survive for long periods. Spores are also resistant to most conventional disinfection methods 
(Lawley et al., 2009). The ability of spores to persist in the environment, is one of the key 
factors in acquisition and transmission of CDI (Borriello et al., 1990).  
Once ingested by the patient, the spores can pass through the stomach and survive low pH 
environment, until they reach the small intestine, where they can start to germinate. Patients 
with CDI episode can excrete high levels of infectious spores to the environment. Moreover, a 
fraction of spores are believed to adhere to the surface of the intestine. These spores, which 
are not affected by antibiotic therapies commonly used for CDI, can then germinate, outgrow 
and recolonize the host gastrointestinal tract before the normal microflora recovers after the 
antibiotic treatment, causing relapse of the disease (Sarker and Paredes-Sabja, 2012). Spores 
are therefore one of the main reasons for recurrence of CDI. 
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Endosporulation is a complex, ancient bacterial process, which aim is to form a highly 
resistant endospore. In this process the vegetative cell type of bacterium is transformed into a 
resistant endospore. External signals are needed to induce the sporulation and to trig the 
signaling cascade of sigma factors, leading to spore formation. For the spore forming bacteria, 
like bacilli and clostridia, the most common signal for initiation of sporulation is starvation. 
Moreover, in the case of C. difficile, an obligate anaerobe, oxygen can cause the initiation of 
sporulation. Recently has been shown that the initial levels of the endosporulation network are 
conserved in evolution between Bacillus subtilis and C. difficile. The sigma factors are the 
key regulators of the pathway, established 2.5 billion years ago upon its emergence at the base 
of the Firmicutes phylum (Pereira et al., 2013). Endosporulation is a highly regulated and 
extremely complex irreversible pathway. Once vegetative bacteria start the sporulation, in no 
case can the pathway be stopped (Piggot and Coote, 1976).  
Spo0A, a master regulator which among other controls the entry of bacteria into the 
developmental process of sporulation, in present in the cell in a phosphorylated and 
dephosphorylated form. Concentration of phosphorylated Spo0A in the cell of B. subtilis 
determines which process will be activated, sporulation or other processes, like biofilm 
formation (Vlamakis et al., 2013). Higher concentration of Spo0A~P presents in the cell 
activates sporulation and represses vegetative cell functions (Piggot and Hilbert, 2004). 
Mutant in Spo0A in C. difficile is unable to form spores (Underwood et al., 2009) and to form 
biofilm (Đapa et al., 2013); (Dawson et al., 2012).  
Until recently, little was known about molecular mechanisms of C. difficile sporulation 
process, and all hypotheses were based on the knowledge from the well-known and well-
understood B. subtilis sporulation pathway (Figure 6a). In this model organism, gene 
expression in the forespore, and in the mother cell, is governed by cell type-specific RNA 
polymerase sigma (σ) subunits. Sporulation is controlled by a cascade of σ-factors. When in 
the vegetative B. subtilis pre-divisional cell high concentrations of Spo0A~P are present, the 
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σH is activated, what leads to an asymmetric division and creation of the prespore, dividing 
prespore from mother cell by a septum (Piggot and Hilbert, 2004). σF is activated in the 
prespore, and σE in the mother cell. σE is responsible for the production of coat proteins for 
the spore and, by communication with the forespore, for the activation of σG in the forespore. 
σG starts a signaling cascade that activates σK, what finally leads to the assembly of the outer 
spore coat (Piggot and Hilbert, 2004). During the formation of the septum, the chromosome 
replicates and forms an axial filament. The remaining section of the chromosome is actively 
transported into the forespore and segregated from the mother cell with the completion of the 
septum. This results in two distinct cells, both with a complete chromosome. The mother cell 
surrounds the forespore and compresses the membrane off in the way to completely envelop 
the forespore. In the forespore the chromosome is now reconstructed into a circular structure, 
the cortex forms a thick layer of cell wall material, and the protective protein spore coat forms 
around, completing in this way the synthesis of the spore. Once spore is completely 
synthesized, the mother cell is lysed, liberating the mature spore.    
For C. difficille it was recently shown that the main periods of activity for the four cell type-
specific σ-sigma factors are conserved relative to the B. subtilis model (Figure 6b) (Pereira et 
al., 2013). σF and σE control the early stages of spore development, and σG and σK are 
responsible for the late developmental stages in spore formation. The main observed 
differences with B. subtilis model were that σE activity was partially independent from σF, and 
that σG or σK did not require σE or σG, respectively (Pereira et al., 2013). Results by Pereira 
and coauthors suggest that the connection between the forespore and mother cell lines of gene 
expression are weaker compared to those observed in B. subtilis.   
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Figure 6 Activity of sigma factors in different stages. Periods of activity for σF, σE, σG and σK are presented 
for B. subtilis (A) and C. difficile (B). Solid or broken arrows represent dependencies or partial dependencies, 
respectively. In C. difficile black indicates the main period of activity. With the broken line and the question 
mark the possible cell-cell signaling pathways are shown. Yellow represents the SpoIIIA-SpoIIQ/CD0125 
channel. PD: predivisional cell; MC: mother cell; FS: forespore. The early (prior to engulfment completion) from 
late (post-engulfment completion) development is distinguished with the red horizontal broken line (Pereira et al., 
2013).   
 
 
 
INTRODUCTION 
 
16 
 
1.1.3.3 Surface virulence factors 
The colonization of the colon is a key factor in the course of CDI. The bacterium can colonize 
exclusively when the normal intestinal microbiota is absent, which makes this step of 
pathogenesis crucial. After the ingestion of the spores, and their germination in the small 
intestine, C. difficile vegetative bacteria can colonize the gut. Just bacteria that adhere to the 
gut, and colonize it, are afterwards able to produce high quantities of the toxins, which cause 
the symptoms of the disease and colonic tissue damage. However non-toxigenic strains of C. 
difficile are still able to colonize the gut and it has been shown that colonization of the animals 
with non-toxigenic strains can prevent colonization with toxigenic strains and in this way 
prevent the disease (Wilson et al., 1982).   
First step in the colonization is the adhesion to the mucosal epithelium. Until now little is 
known about the interactions between C. difficile and the gut. It is known that C. difficile can 
associate with intestinal mucosa in humans and hamsters, and the positive correlation between 
virulence and mucosal adherence in vivo has been observed (Borriello et al., 1988). C. difficile 
can persist in the gut regardless of physical stresses, e.g. shed of the colonic mucosa from the 
epithelial surface during the infection and the flow of luminal contents in the colon, which 
creates an environment with considerable mechanic force. This suggests that the adhesion of 
C. difficile to the gut, and surface-associated virulence factors, play an important role during 
CDI. In the last few years several surface factors, involved in adhesion and colonization of the 
bacteria, have been identified and partially characterized.   
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1.1.3.3.1 Surface layer proteins (SLPs) 
Surface layer proteins (SLPs), also called S-layer, are surface-associated crystalline or 
paracrystalline arrays, formed by identical subunits of glycoproteins or proteins. SLPs are 
present in many prokaryotes (Sara and Sleytr, 2000). 
Functions including acting as molecular sieves, protective factors against parasitic attack, 
virulence factors and adhesion sites for extracellular proteins, were attributed to bacterial S-
layers (Sara and Sleytr, 2000). C. difficile S-layer is composed of two superimposed and 
structurally different S-layer lattices, a high-molecular-weight (HMW) SLP (40 kDa) and a 
low-molecular-weight (LMW) SLP (35 kDa) (Figure 7a) (Cerquetti et al., 2000); (Calabi et al., 
2001); (Karjalainen et al., 2001). Both, HMW and LMW are transcribed by the same gene, 
slpA. Proteins are then subject to a post-translational cleavage of a common precursor, with 
the N-terminal portion coding for the LMW SLP, and the C-terminal portion coding for the 
HMW SLP (Calabi et al., 2001). The translated gene product, slpA, then undergoes two post-
translational cleavages. In first, the signal sequence is removed, following secretion, and then 
internally to release the two mature SLPs (Figure 7). HMW and LMW are tightly linked by a 
non-covalent complex (Fagan et al., 2009). HMW SLP, localized in the internal surface of the 
bacterium, is immunologically conserved. LMW SLP, localized at the external surface of the 
bacterium, is immunologically variable (Cerquetti et al., 2000); (Takeoka et al., 1991); (Fagan 
et al., 2009), and suggests a role for LMW SLP in evasion of the immune system (Vedantam 
et al., 2012). Chemical treatment, or treatment of C. difficile bacterial cells with anti-SLP 
antibodies, cause the removal of the SLPs. Bacteria with removed SLPs showed an abolished 
adherence of C. difficile in the animal model and human HeLa cells, indicating the role of 
SLPs in adhesion to the host (Takeoka et al., 1991). Purified SLPs can bind to intestinal 
tissues and several proteins of the extracellular matrix (Calabi et al., 2002), but the precise 
host receptor remains unknown.   
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Figure 7 Clostridium difficile cell wall model. (A) Two types of surface layer proteins are presented. High-
molecular-weight (HMW) SLP are presented as light grey molecules, and low-molecular-weight SLP as dark 
grey. Two-lobed structures (white) indicate other minor cell wall proteins. Vertical black bars represent putative 
cell wall polymers. (B) The precursor protein SlpA showing the cleavage sites generating the signal peptide (    ) 
and the mature HMW SLP and LMW SLP (   ) (Fagan et al., 2009). 
 
1.1.3.3.2 Cell wall proteins (CWPs) 
C. difficile 630 genome contains 28 paralogs of the HMW SLP, which are known as the 
family of cell wall proteins (CWPs) (Sebaihia et al., 2006). All CWPs contain up to three 
copies of the cell wall-binding motif (PF01422), a motif characteristic of the SLPs, which is 
involved in anchoring the protein to the outer surface of the bacterium, and a variable motif, 
that might be function-specific (Sebaihia et al., 2006). 
Cwp84 is a cysteine protease conserved in various C. difficile strains (Savariau-Lacomme et 
al., 2003). It is localized in the locus containing the slpA gene. Presence of Cwp84 was 
detected in antisera from patients with CDI, suggesting Cwp84 may play a role in C. difficile 
pathogenesis (Pechine et al., 2005a). Cwp84, a cysteine protease, is likely synthesized as an 
inactive proprotein of 80 kDa, which then autoprocesses itself to a 47 kDa mature Cwp84 
(Janoir et al., 2007); (ChapetonMontes et al., 2011). Using chemical and genetic techniques it 
was shown that cysteine protease Cwp84 mediates the cleavage of the mature SlpA precursor 
(Kirby et al., 2009); (Dang et al., 2010). SlpA in a C. difficile cwp84 mutant weakly binds the 
bacterial cell wall due to the lack of formation of the mature S-layer (Kirby et al., 2009). 
Correct processing of SlpA is important for the maturation of S-layer of the bacteria. Despite 
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this, a C. difficile cwp84 mutant is able to cause infection (Kirby et al., 2009). Cwp84 is also 
involved in degradation of fibronectin, vitronectin, and laminin,and hence it is likely that in 
this way it induces a loss in the integrity of the host’s colonic epithelium and increases the 
diffusion of toxins (Janoir et al., 2007). 
  
1.1.3.3.3 Flagella 
Mobility of the bacterium is an important physiological factor. For Campylobacter jejuni and 
Legionella pneumophila flagella plays an important role in internalization of the bacterium 
(Dietrich et al., 2001); (Grant et al., 1993), and in adherence and colonization of 
Campylobacter jejuni (McSweegan and Walker, 1986) and Helicobacter pylori (Eaton et al., 
1996). Nonflagellated strains of C. difficile showed a tenfold reduced adherence to tissue in 
the mouse cecum, compared to flagellated strains belonging to the same serogroup, indicating 
an important role of flagella in adherence (Tasteyre et al., 2001a); (Tasteyre et al., 2001b).   
Sera from patients with CDI have shown the presence of two important proteins in synthesis 
of flagella, FliC and FliD, associating them as important virulence factors during the CDI 
(Pechine et al., 2005a); (Pechine et al., 2005b). 
Inactivation of either the flagellin (fliC) or flagellar cap (fliD) genes results in complete loss 
of flagella and motility of C. difficile (Dingle et al., 2011). Unexpectedly, both mutants, fliC 
and fliD, adhere more to enterocyte-like Caco-2 cells and were more virulent in the hamsters 
compared to the wild-type C. difficile (Dingle et al., 2011). Microarray and real-time PCR 
results suggest that when the vegetative cell C. difficile enters in contact with Caco-2 cells 
there is a downregulation of the genes involved in assembly of flagella (i.e., fliH and flgG) 
(Janvilisri et al., 2010). From these results we can conclude that the flagellum is adequately 
regulated to aid motility when in the colonic lumen and adherence when in contact with Caco-
2 cells (Vedantam et al., 2012).  
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1.2 BIOFILMS 
Biofilms are communities of surface-associated microorganisms, encased in a self-produced 
extracellular matrix. Formation of the biofilm is a common way of bacterial life cycle, and 
biofilms are found on practically all natural and artificial surfaces. Biofilms are well studied 
because they represent an important example of microbial lifecycle (Vlamakis et al., 2013). In 
the last decades, the role of biofilms was pushed to the forefront because of its function during 
an infection. Majority of bacterial infections is caused by bacteria in form of biofilms. 
Biofilms are ubiquitous in the nature, and are a prevalent form of microorganisms living in 
natural, industrial, and hospital settings (Hall-Stoodley et al., 2004). Bacteria in the biofilm 
are enclosed in self-produced extracellular matrix, which is essential for the integrity of the 
biofilms, and which holds the communities together (Flemming and Wingender, 2010). 
It is well known that formation of biofilms influences the ability of several pathogens to 
colonize and establish an infection (Nobbs et al., 2009); (Allsopp et al., 2010). Biofilms 
provide an enclosed environment to escape immune responses and resist to antibiotics (Beloin 
et al., 2008); (Mah and O'Toole, 2001). We recently showed that C. difficile is able to form 
biofilms in vitro, an ability which could be crucial for clostridial colonization and persistence 
in the host (Đapa et al., 2013); (Dawson et al., 2012). 
 
1.2.1 History 
After inventing the microscope, Antonie van Leewenhoek, in 1684, published the first record 
describing biofilm structures. His report in the Royal Society of London was describing the 
vast accumulation of microorganisms observed in dental plaque: "The number of these 
animalcules in the scurf of a man's teeth are so many that I believe they exceed the number of 
men in a kingdom." 
However, for long time after the first biofilm report, microorganism were primarily studied as 
planktonic, freely suspended cells, and their characteristics were described on the basis of 
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their growth in nutritionally rich culture media (Donlan, 2002). It was in 1973 when 
Characklis reported a study on microbial slimes in industrial water systems and showed that 
attached microbial growths are very tenacious and highly resistant to disinfectants such as 
chlorine. In 1978, Costerton et al. (Costerton et al., 1978), based on observations of dental 
plaque and sessile communities in mountain streams, put forward the theory of bacteria that 
stick together as biofilms, and explained the mechanisms by which microorganisms adhere to 
living and non-living materials, and the benefits accrued by this ecologic niche.  
Since then, number of research and article published on the topic of biofilms increased 
dramatically. Not just studies relevant for public health, but knowledge on biofilms in 
industrial and ecologic settings also greatly improved. Tools for studying standard 
microbiologic culture techniques for biofilm characterization and biofilm genetics were 
developed (O'Toole and Kolter, 1998). Much of the work has relied on microscopy, e.g. 
scanning electron microscopy (SEM), and recently confocal microscopy and confocal 
scanning laser microscopy (CSLM). All these tools had a dramatically impact on our 
understanding of biofilms.  
 
1.2.2 Biofilm structure 
Bacteria in the biofilm are organized in three-dimensional bacterial communities, surrounded 
and entrenched by a self-produced extracellular matrix (Costerton et al., 1999). Biofilms are 
usually attach to the surface, either to a living or a non-living surface (Stoodley et al., 2010); 
(Yang et al., 2008); (Fux et al., 2004). Bacterial cells in the biofilm are morphologically and 
physiologically different from planktonically cultured cells.  
Genetically identical bacteria within the monoculture biofilm express different genes at the 
same time, and in this way produce subpopulations of functionally different cell types 
(Vlamakis et al., 2008). Bacteria in the biofilms exist in heterogeneous communities (Hall-
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Stoodley et al., 2004), and consequently show community behavior and functions, specialized 
for biofilm form of life (Vlamakis et al., 2008). 
 
1.2.3 Biofilm formation and development 
The switch between a planktonic cell and a biofilm community lifestyles brings a change in 
gene expression, which leads to varying phenotypes. The first step in a formation of a biofilm 
multistructural community is attachment of planktonic cells to a surface, creating in this way a 
microcolony. Bacteria in the microcolony communicate through quorum sensing (QS). QS is 
a form of cell-cell communication between bacteria, based on a system of stimulus and 
response correlated to population density. QS allows bacteria to analyse and sense population 
density through a series of secreted signals and receptors, and enable the bacteria itself to 
coordinate the behavior and respond to environmental factors (Hall-Stoodley et al., 2004); 
(Hall-Stoodley and Stoodley, 2005).  
After the initial attachment (Figure 8) and formation of the microcolony, the microcolony 
starts to expands through recruitment of additional planktonic cells and cell divisions. 
Bacteria start to produce extracellular matrix, which later encase the attached bacteria. In 
biofilms the microorganisms account for less than 10% of the dry mass, 90% is surrounding 
self-produced extracellular matrix that covers and protects the bacteria. The extracellular 
matrix, hydrated biopolymers, composed of protein, nucleic acid, and polysaccharides, is 
called extracellular polymeric substance (EPS) (Flemming and Wingender, 2010).  
During the next steps, aggregation and maturation of the biofilm (Figure 8), the 
microorganisms encapsulated in the biofilm start to actively replicate and increase the total 
density and complexity of the biofilm. Biofilm architecture matures as a result of interactions 
between the microbial colonies and extracellular substances (Davies et al., 1998). The gene 
expression and synthesis of proteins is different compared to planktonic growth (Sauer et al., 
2002); (Whiteley et al., 2001). Mature biofilms, 3D structures, form porous and in some cases 
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contain channels which help the distribution of nutrient and signaling molecules (Costerton et 
al., 1999); (Hall-Stoodley et al., 2004); (Fux et al., 2004); (Hall-Stoodley and Stoodley, 2005).  
The last step in biofilm development is dispersion of the biofilm (Figure 8). Numerous 
environmental conditions determine the moment when biofilms reach its critical mass and 
when the dispersion of biofilm starts. Such conditions are availability and perfusion limitation 
of nutrients and wastes. With the dispersion of motile cells from a mature biofilm bacteria can 
now colonize new surfaces. Disassembly of the biofilm causes continuous release of single 
cells, spores, or small clusters, over an extended period. Biofilm dispersal can releases large 
portions of the biofilm late in biofilm development. Dispersal is a rapid method of spreading 
and releasing single cells or small clusters. Several matrix-degrading enzymes, e.g. proteases, 
deoxyribonucleases, DNases, and glycosidases, can cause the dispersal and disassembly of 
biofilm (Kaplan, 2010). It has been shown that nitric oxide and D-amino acids can cause the 
dispersal of B. subtilis biofilm (Schreiber et al., 2011); (Kolodkin-Gal et al., 2010), however 
recent data called into question the role of D-amino acids in biofilm disassembly, as it seems 
D-amino acids inhibit growth of B. subtilis itself (Leiman et al., 2013).   
With the maturation of the biofilms, many morphological changes occur to the cells within the 
biofilms. The number of motile cells decreases with the progression of biofilm formation, 
although a small subpopulation of motile cells remains in the mature Bacillus subtilis biofilms 
(Vlamakis et al., 2008). The role of these motile cells in B. subtilis biofilms varies depending 
on growth conditions. Mutants defected in motility, which do not have flagella, are delayed in 
forming B. subtilis pellicle biofilms (Kobayashi, 2007b), and are defective in the formation of 
submerged, surface-adherent biofilms (Chagneau and Saier, 2004). 
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Figure 8 The life cycle of a Bacillus subtilis biofilm. Different stages of biofilm formation. Main stages are 
development, maturation and disassembly of the bacterial community. After the initial attachment to the surface 
motile cells differentiate into non-motile and matrix-producing cells. In this stage cells stop separating and form 
chains, surrounded by self-produced extracellular matrix. Next step is maturation of biofilms, where B. subtilis 
cells start to sporulate, followed by biofilm disassembly. In biofilms, different functionally distinct cell types 
exist, but these cells are genetically identical, and differentiation into a specific cell type is not terminal and can 
be altered when environmental conditions change (Vlamakis et al., 2013). 
 
1.2.4 Role of biofilms during the infections 
Bacteria within biofilms are protected and more resistant to different environmental stresses, 
e.g. antibiotic or oxygen stress (Davey and O'Toole G, 2000). But biofilms protect bacteria in 
myriad of other ways. Bacteria in the biofilms are more resistant to antibiotics, biofilms help 
bacteria to avoid phagocytosis, support bacterial adherence to the epithelial tissues, and 
exclude host defense molecules like antibodies and anti-microbial peptides (Hall-Stoodley 
and Stoodley, 2009); (Parsek and Singh, 2003). Resistance to the antibiotics can be up to 
thousand times higher for bacteria in the biofilm compared to bacteria in the planktonic 
growth (Stewart and Costerton, 2001). These are the reasons why majority of human 
infections is caused by bacteria in biofilms.  
Common diseases as dental caries and periodontitis are caused by bacteria in biofilm, and 
biofilm formation has been connected with persistent tissue infections such as chronic otitis 
media, chronic rhinosinositis, recurrent urinary tract infections, endocarditis and cystic 
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fibrosis-associated lung infections (Costerton, 1999). Recently, biofilms were also associated 
with chronic inflammatory diseases as Crohn’s disease (Claret et al., 2007), and acute 
infections (Hannan et al., 2012); (Kumagai et al., 2011). Moreover, biofilms represent a big 
problem when formed on artificial devices used in medicine, as catheters, stents, orthopaedic 
implants, contact lenses and implantable electronic devices (Costerton, 1999); (Lynch and 
Robertson, 2008). Resistance, of bacteria within biofilms to the antimicrobials, makes 
treatment of disease difficult and unsuccessful. Furthermore, mature biofilms are highly 
resilient to the action of the innate and adaptive immune defense systems, and for several 
pathogens recurrent and persistent infections have been associated with the ability to form 
biofilms (Romling and Balsalobre, 2012). Therefore due to enhanced antibiotic resistance, 
and evasion of host defenses, biofilm infections can be especially difficult to treat.  
Biofilms are found in many niches in the mammalian host, including the surface of the gut 
mucosa (Bollinger et al., 2007); (Palestrant et al., 2004); (Probert and Gibson, 2002), however, 
biofilm formation by individual gut species, particularly anaerobic species, has not been well 
characterized. In addition to spore formation, a known means of adaptation to stress, it is 
likely that C. difficile forms microcolonies in vivo to survive the unfavorable environment of 
the human gut. 
 
1.2.5 Antibiotics and biofilms                                     
One of the main functions of a biofilm is to protect bacteria from unfavorable conditions like 
antibiotics, particularly during the infections. The role of bacterial biofilms in resisting 
antibiotics has been well demonstrated for many pathogenic species, including methicillin-
resistant Staphylococcus aureus (Olson et al., 2011). Resistance to antibiotics in biofilm can 
increase from 10- to 1,000-fold more compared to planktonic bacteria (Mah and O'Toole, 
2001). An increase in the number of recurring clostridial infections (Kelly, 2012), and a rise 
in C. difficile strains resistant to drugs currently used for the treatment, such as metronidazole 
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and rifampicin, have made management of CDI difficult (Carman et al., 2012); (Surawicz and 
Alexander, 2011).  
Antibiotics at minimal concentrations, on the other hand, could also act as stress signals and 
biofilm formation could be a defensive reaction to the presence of antibiotics, as shown for 
Gram negative bacteria Escherichia coli and Pseudomonas aeruginosa (Boehm et al., 2009); 
(Hoffman et al., 2005). Induction of biofilms in presence of sub-inhibitory concentrations of 
antibiotics has been previously attributed to alterations in the level of c-di-GMP (Hoffman et 
al., 2005). Such induction in vivo could be clinically relevant when there is exposure to low 
doses of antibiotics, like at the beginning or at the end of antibiotic therapy, which could 
perhaps explain ineffective treatment (Boehm et al., 2009). 
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1.3 EXAMPLES OF REGULATION OF BIOFILM FORMATION  
1.3.1 Bacillus subtilis 
Bacillus subtilis is a non-pathogenic, aerobic, spore forming, Gram-positive bacterium. In the 
past years this bacterium arose as a model Gram-postive organism for studying the molecular 
basis of different pathways, e.g. sporulation and biofilm formation. B. subtilis, as C. difficile, 
belongs to the phylum Firmicutes, which makes the comparison of two bacteria more relevant, 
even though there are many differences between them.   
In natural settings B. subtilis forms biofilm on plant roots, where provides benefits to the plant. 
B. subtilis requires a nutrient source, such as decaying organic material or plant roots, in order 
to proliferate in the soil. On the other hand, bacteria in the rhizoshere can benefit the plant 
with promoting the growth and protect plants from pathogenic bacteria, fungi and nematodes. 
In response to the presence of B. subtilis, the plant induced systemic resistance, and coupled 
with the secret antimicrobial compounds by B. subtilis, enhances the capacity of the plants to 
resist various pathogens (Vlamakis et al., 2013). It has been shown that biofilm formation on 
plant roots requires, as the biofilm formation in vitro, expression of exopolysaccharide matrix. 
Extracellular matrix holds the cells together. Plant polysaccharides, the major components of 
the plant’s cell wall, triggers biofilm formation by B. subtilis and serves as a carbon source 
used to produce the extracellular matrix (Figure 9) (Beauregard et al., 2013).  
First step in biofilm formation is the expression of matrix genes in response to an external 
signal, e.g. lipopeptide surfactin. Short motile rod cells turn into long chains of non-motile 
cells, which adhere to each other and to the surface with the development of biofilm. Bacteria 
secret self-produced extracellular matrix (Vlamakis et al., 2013). In addition to the cells 
expressing genes for matrix production, motile cells and spores are present in B. subtilis 
biofilm. Different cell types together form a mature biofilm. The presence and the localization 
of this different cell types within the biofilm is dynamic and there are evidences of an order 
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sequence of differentiation. Motile cells become matrix-producing cells, which then 
eventually start the sporulation and turn into spores (Vlamakis et al., 2008). 
 
 
Figure 9 Bacillus subtilis biofilm in natural settings. For the B. subtilis colonization of plant’s roots the 
production of surfactin is required. Surfactin is an antimicrobial lipopreptide, and together with other lipopetides 
produced by B. subtilis is one of the main mechanisms for plant biocontrol. These molecules can induce systemic 
resistance and inhibit the growth of plant pathogens as Pseudomonas syringae. In case, when the plant is infected 
with P. syringae, the plant secretes malic acid, what enhances B. subtilis biofilm formation on the root (Vlamakis 
et al., 2013). 
 
In laboratory conditions B. subtilis biofilm can form different types of biofilm structures 
(Figure 10). The most studied forms of biofilm for B. subtilis are colony biofilms at the air–
agar interface, floating biofilms at the air–liquid interface (also termed pellicles) and, in the 
case of certain domesticated strains, submerged, surface-adhered biofilms at the liquid–solid 
interface. Colony biofilm forms a complex wrinkled colony within a few days. Formed 
wrinkles are a consequence of localized death cell, coupled with the rigidity provided by the 
extracellular matrix (Branda et al., 2001); (Asally et al., 2012). In the liquid media the 
formation of the biofilm will occur on the surface of the liquid, in case when the cells will 
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float to the surface of the liquid, produce extracellular matrix and form a pellicle at the air–
liquid interface, or they will form biofilm at the side of the culture vessel, in case when the 
cells remain under the surface of the liquid, where they form a submerged biofilm. Type of 
the formed biofilm from B. subtilis varies depending on the strain and the experimental 
conditions used (Vlamakis et al., 2013). 
 
 
Figure 10 B. subtilis biofilm in laboratory conditions. (A) Seven days old B. subtilis colony, grown on biofilm 
inducing medium (MSgg medium). (B) Five days old B. subtilis pellicle, grown at room temperature (Branda et 
al., 2001). 
 
Extrapolysaccharide matrix is major component in B. subtilis biofilm. EPS is synthesized by 
the products of the epsABCDEFGHIJKLMNO operon. Two additional characterized structural 
proteins, present in B. subtilis biofilm matrix, are translocation-dependent antimicrobial spore 
component (TasA), and biofilm surface layer protein BslA (Vlamakis et al., 2013) TasA 
protein assembles into long amyloid-like fibres, which are attached to the cell wall by another 
protein, TapA (Romero et al., 2010); (Romero et al., 2011). TasA was the first described 
protein component of the extracellular matrix of colony and pellicle biofilms (Branda et al., 
2006). BslA, another secreted protein, is important for surface hydrophobicity, complex 
colony morphology and pellicle formation (Kobayashi and Iwano, 2012); (Kobayashi, 2007a); 
(Kovacs and Kuipers, 2011); (Verhamme et al., 2009).  
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One of main regulator of B. subtilis biofilm formation is master regulator Spo0A. Spo0A, 
central transcriptional regulator, controls the expression of more than 100 genes, including 
genes for biofilm matrix expression and sporulation (Fujita et al., 2005); (Molle et al., 2003). 
Spo0A is regulated by phosphorylation, concentration of phosphorylated or unphosphorylated 
forms of Spo0A (Spo0A~P) determinates gene expression. Spo0A is activated by 
phosphorylation as response to nutrient limitation (Burbulys et al., 1991); (Fujita and Losick, 
2005). Both forms, phosphorylated and unphosphorylated form, are always present in the cell. 
Intermediate levels of Spo0A~P induce matrix gene expression, and higher levels induce the 
sporulation of B. subtilis. With maturation of the biofilm, and accumulation of Spo0A~P in 
the cell, sporulation is activated.  
In B. subtilis at least four kinases (KinA, KinB, KinC and KinD) are responsable for 
phosphorylation of Spo0A~P. The pathway starts with phosphorylation of Spo0F by KinA, 
KinB, KinC or KinD. Spo0F~P then pass the phosphoryl group to Spo0B, which goes on to 
phosphorylate Spo0A. Depending on the enviromental signals different kinases are 
responsible for matrix gene expression (Hamon and Lazazzera, 2001); (McLoon et al., 2011); 
(Lopez et al., 2009). In C. difficile it has been suggested that phosphorylation of Spo0A 
occurs directly by a sporulation-associated sensor kinase. Kinase HK CD1579 was able to 
directly, and specifically, phosphorylate Spo0A (Underwood et al., 2009). 
Spo0A~P in B. subtilis regulates several genes responsible for matrix production. The main 
regulatory pathway, governed by Spo0A~P, is by controlling the activity of the master 
regulator SinR. SinR is a repressor of the eps and tapA–sipW–tasA operons (Vlamakis et al., 
2013). SinR antirepressor, SinI, is under the control of Spo0A~P. When SinI is expressed, it 
forms a SinI-SinR complex, which renders SinR incapable of binding to DNA (Lewis et al., 
1996). Regulator SinR is expressed in all cells, but is inactivated just in the cells producing 
antirepressor SinI. As a result, only a subpopulation of cells expresses the the tapA–sipW–
tasA and eps operons (Vlamakis et al., 2008); (Chai et al., 2008). Moreover, Spo0A~P 
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represses a second matrix gene repressor, AbrB (Strauch et al., 1990). AbrB represses tapA– 
sipW–tasA and eps operons as well (Vlamakis et al., 2013).  
AbrB represses the abh gene (Strauch et al., 2007), however, the abh gene transcription is 
controlled by several extracytoplasmic function (ECF) RNA polymerase σ-factors, including 
σM, σW and σX. This ECF σ-factors are activated by enviromental stimuli, e.g. cell wall stress 
and specific antibiotic stresses (Helmann, 2002). In this way the bacterium can respond to 
enviromental changes in a Spo0A independent way (Vlamakis et al., 2013).   
The regulators described are just few mechanisms that control biofilm formation by B. subtilis 
(Figure 11), and suggest the complexity and multilayered regulatory mechanisms that control 
biofilm formation in B. subtilis.  
 
Figure 11 Shematic regulatory network that controls biofilm formation in Bacillus subtilis. Many different 
pathways regulate biofilm formation by B. subtilis (subnetworks I-IV). Main regulatory pathway is the Spo0A 
dependent pathway. However, different enviromental conditions may activate different Spo0A independent 
pathways. The role of all pathways is repression or activation of expression of biofilm matrix genes: the eps 
(exopolysaccharide synthesis) operon, the tapA–sipW–tasA (TasA anchoring and assembly–type I signal 
peptidase W–translocation-dependent antimicrobial spore component) operon, the bslA (biofilm surface layer) 
gene and the pgs (γ poly dl glutamic acid synthesis) operon. In the schematic presentation, dark grey and blue 
lines indicate transcriptional regulation, and light grey lines indicate protein–protein interactions. Direct and 
indirect regulation is presented with solid and dashed lines, respectively (Vlamakis et al., 2013).   
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1.3.2 Staphylococcus epidermis  
Staphylococcus epidermis is an important representative of staphylococci and is one of main 
commensal skin bacterium, but is also recognized as an opportunistic pathogen. Majority of S. 
epidermis infections are associated with the formation of biofilm on medical devices, e.g. 
vascular catheters and prosthetic graft materials (Otto, 2012).  
S. epidermis, as an important skin commensal, plays an important role in maintaining a 
healthy skin flora, providing so-called colonization resistance (Stecher and Hardt, 2008). It is 
believed that S. epidermis competes with potentially harmful bacteria (Otto, 2012). For 
example, it has been suggested that S. epidermis inhibits the agr quorum sensing reponse of 
Staphylococcus aureus (Otto et al., 2001), and it has been shown that extracellular serine 
protease (Esp), produced by S. epidermidis, inhibits S. aureus biofilm formation (Iwase et al., 
2010).  
The pathogenesis of S. epidermidis is dependent on its ability to form biofilms on polymeric 
surface (Anglen et al., 1994); (Ziebuhr et al., 1997). First step in S. epidermidis biofilm 
formation is attachment of bacterial cells to a polymer surface. It is a complex process, 
dependent by multiple different factors, e.g. hydrophobic interactions, the presence of host 
proteins, specific staphylococcal factors like the capsular polysaccharide adhesin, the 
autolysin AtlE, and other staphylococcal surface proteins (Knobloch et al., 2004). In the 
second phase, after the attachment, accumulation of bacteria in a multilayered biofilm 
embedded in an amorphous glycocalyx occures. For S. epidermidis, cell accumulation is 
essential for the synthesis of the polysaccharide intercellular adhesin (PIA), which mediates 
cell-to-cell adhesion of the proliferating cells (Mack et al., 1996a); (Mack et al., 1996b); 
(Mack et al., 1994); (Mack et al., 1992).  
It has been shown that operon of alternative sigma (σ) factor B plays an important role in 
biofilm formation by S. epidermidis (Knobloch et al., 2004). The function and regulation of 
alternative σ-factor B is well studied and understood in other Gram positive bacteria like 
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Bacillus subtilis and Staphylococcus aureus. The initiation of transcription in bacteria 
depends on the sigma factors that associate with the RNA polymerase core enzyme. Several 
alternative sigma factors are associated with different promoter specificities, and binding of σ-
factors to the promotors results in a changes in the patterns of gene expression.  
Numerous environmental stresses, e.g. signals of energy stress like carbon, phosphate or 
oxygen starvation, and salt, heat, acid, or ethanol shock stresses, can induce σ-factor B in B. 
subtilis (Hecker et al., 1996). The alternative σ-factor B in B.subtilis is controlled by a 
complex signal transduction pathway (Boylan et al., 1992); (Wise and Price, 1995). RsbVW 
partner-switching controls σ-factor B activity in B. subtilis and is highly conserved among 
Gram positive bacteria that contain σ-factor B operon (Figure 12) (de Been et al., 2011). In 
normal conditions σ-factor B is in an inactive state, forming a complex with the anti-sigma 
factor RsbW. When stress conditions occurs, the release of σ-factor B from RsbW is 
accomplished by anti-anti σ-factor RsbV, which upon dephosphorylation, sequesters RsbW. 
Anti σ-factor RsbW in addition acts as a kinase of RsbV, providing a negative feedback on 
activation of σ-factor B. RsbV is dephosphorylated during the stress conditions, sequestring in 
this way RsbW, and activating σ-factor B (Hecker et al., 2007). In addition to RsbV, RsbU 
was shown to be a positve regulator of σ-factor B activity (Palma and Cheung, 2001). 
σ-factor B positvily controls many different genes. In B. subtilis more than 100 genes are 
under σ-factor B control, which are induced by different stresses (Palma and Cheung, 2001). 
In S. aureus several different factors were shown to be included in σ-factor B regulon (Kullik 
et al., 1998); (Nicholas et al., 1999).  
Knobloch and co-workes (2004) were studying biofilm formation for Staphylococcus 
epidermis in mutants rsbU, rsbV, sigB, rsbW, rsbUVW and rsbUVWsigB, in two different 
backgrounds. Significant decrease in biofilm formation has been observed in mutants rsbU, 
rsbV, sigB and rsbUVWsigB. In mutants for anti sigma-factor rsbW, and in mutant rsbUVW, 
however, a significant increase in biofilm formation was observed. Deletion of the positive 
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regulators of σ-factor B, and σ-factor B itself, represses the transcription of genes in σ-factor 
B regulon. In contrast, the lack of anti sigma-factor RsbW, enable the binding of σ-factor B 
with the RNA polymerase core enzyme, and allows the transcription of genes in σ-factor B 
regulon. This suggests that gene or several genes in σ-factor B regulon are involved in biofilm 
formation by S. epidermidis (Knobloch et al., 2004).  
 
 
Figure 12 Regulatory pathway for the activity of the alternative σ-factor B. The pathway is highly 
conserved among Gram positive bacteria that contain σ-factor B operon. RsbW is an anti-σ factor and negatively 
regulates σ-factor B activity. Moreover RsbW act as a specific kinase for the anti-anti-σ factor RsbV, which, 
once phosphorylated, is unable to bind to RsbW. RsbV can be activated by dephosphorylation by specific 
phosphatase RsbU. Active, dephosphorylated, RsbV can bind anti-σ factor RsbW, what derepresses σ-factor B 
(Knobloch et al., 2004).   
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2 MATERIALS AND METHODS  
2.1 BACTERIAL STRAINS AND CULTURE CONDITIONS  
Two C. difficile strains, 630 and strain B1/NAP1/027 R20291 (isolated from the Stoke 
Mandeville outbreak in 2004 and 2005), were used in our studies. Bacteria were grown in 
liquid or solid media at 37°C under anaerobic conditions (80% N2, 10% CO2, 10% H2), in a 
Don Whitley workstation (Yorkshire, United Kingdom).  
Bacteria from glycerol stocks were grown overnight on BHIS plates. One single colony was 
inoculated in 5ml of liquid BHIS and grown overnight to stationary phase for biofilm assay, 
or to logarithmic phase for growth curve experiments.  
For the second selection in the genetic manipulation of C. difficile a minimal medium was 
used (CDM), prepared according to Cartman and co-workers (Cartman et al., 2012). 
Where appropriate the medium was supplemented with 15μg/ml thiamphenicol (Sigma-
Aldrich, USA) or 20μg/ml of lincomycin (Sigma-Aldrich, USA). All medium was pre-
incubated before use for at least 12hrs under anaerobic conditions.  
All Escherichia coli strains were grown in Luria-Bertani (LB, Bacto, USA) at 37°C, 
supplemented with 20μg/ml chloramphenicol when required. E. coli strain DH5α (Invitrogen) 
was used for cloning, and E. coli strain CA434 was used as a conjugative donor. 
Growth curves for bacteria were performed in BHIS containing 0.1M glucose. Overnight 
cultures of C. difficile R20291 and mutants were diluted to a starting OD600 of 0.05 and re-
grown to mid-exponential phase (0.4-0.8). Cultures were then diluted to OD600 0.01, and 
OD600 was measured every hour for 12hrs. All measurements were performed in triplicates. 
Compositions of all the culture media used in this study are reported in Appendix 1, and list 
of all bacterial strains and plasmids in Appendix 2. 
 
MATERIALS AND METHODS 
36 
 
2.2 BIOFILM FORMATION ASSAY AND MEASUREMENT OF BIOFILM BIOMASS 
For generation of biofilms, overnight cultures of C. difficile were diluted 1:100 into fresh 
BHIS, containing 0.1M glucose, and incubated in the tissue culture treated 24-well 
polystyrene plates (Costar, USA), 1ml per well, in anaerobic conditions at 37°C for 1hr to 
120hrs. 24- or 48-well cell culture plates were pre-incubated in anaerobic conditions for 48hrs 
prior to use. To prevent evaporation of liquid, plates were wrapped with parafilm. 
Measurement of biofilm biomass with crystal violet was done as described in previously 
published methods (Varga et al., 2008). After the required incubation, wells of the 24-well 
plate were gently washed with sterile phosphate buffered saline (PBS) and then allowed to dry 
for 10min. The biofilm was stained with 1ml of filter-sterilized 0.2% crystal violet and 
incubated for 30min at 37°C, in anaerobic conditions. Crystal violet was removed from the 
wells, followed by two washes with sterile PBS. The dye was extracted by adding 1ml 
methanol to each well and incubation for 30min at room temperature (RT) in aerobic 
conditions. The methanol-extracted dye was diluted 1:1, 1:10 or 1:100 and A570 was 
measured with spectrophotometer Ultrospec 500 pro (Amersham Biosciences).  
For bacterial cell counts from biofilms, the planktonic phase was first removed and wells were 
washed with sterile PBS. The adherent biofilms were then detached by scraping with a sterile 
pipette tip, washed in PBS, and plated on BHIS for determination of the number of CFU 
present in the biofilm. 
 
2.3 ENZYMATIC INHIBITION OF BIOFILMS  
Proteins, extracellular DNA and polysaccharides are known to be an important part of 
extracellular biofilm matrix. To study the presence and the role in biofilm formation of 
proteins and extracellular DNA in C. difficile biofilms, 0.1mg/ml of proteinase K and 2U/ml 
DNase I was added to biofilm at time 0. To see if these enzymes affect preformed biofilms, 
biofilms were allowed to form in 24-well plate as described above and washed with sterile 
MATERIALS AND METHODS 
37 
 
PBS. Fresh BHIS 0.1M Glc with 0.1mg/ml proteinase K or 2U/ml DNase I was added and the 
biofilms were incubated for a further 24hrs, followed by staining with 0.2% crystal violet as 
described above.  
 
2.4 CONFOCAL MICROSCOPY ANALYSIS OF BIOFILM FORMATION 
C. difficile strains were grown in 4-well glass chamber slides (BD Falcon, USA), in BHIS 
0.1M glucose, at 37°C in anaerobic conditions for 24hrs or 72hrs, and stained with various 
staining reagents. For biofilm staining with fluorescent BacLight Live/Dead stain mixture 
(Molecular Probes, Invitrogen), which contains the nucleic acid stains Syto 9 and propidium 
iodide (staining live bacteria green and dead bacteria red, respectively), wells were gently 
washed twice with PBS 0.1% saponin to remove unattached cells and incubated with dye for 
15min at 37°C. The wells were additionally washed twice, and before removing from the 
anaerobic chamber, bacteria were fixed with 4% PFA (paraformaldehyde) for 15min. 
For immunoflourescent staining bacteria were fixed with 4% PFA for 15min, washed three 
times with 2% bovine serum albumin (BSA)/PBS and blocked with 2% BSA and 0.1% 
saponin in PBS for 10min. Samples were then incubated with mouse serum against fixed 
R20291 strain or against a synthetic C. difficile PSII polysaccharide (synthetic phosphorylated 
hexasaccharide repeating unit) (Adamo et al., 2012), diluted 1:1000 for 1hr, followed by 
incubation with Alexa Fluor 568 goat anti-mouse antibodies diluted 1:500 for 1hr. Anti C. 
difficile antibodies were in house generated against paraformaldehyde-fixed whole bacteria in 
mice. 
Biofilm matrix was labeled by SYPRO Ruby biofilm matrix stain (Molecular Probes, 
Invitrogen) which stains matrices of biofilms (labels most classes of proteins, including 
glycoproteins, phosphoproteins, lipoproteins, calcium binding proteins and fibrillar proteins). 
After two washes with sterile PBS 0.1% saponin, samples were incubated for 30min with 1ml 
of Ruby biofilm matrix stain at room temperature. 
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All chamber slides were mounted with ProLong Gold Antifade Reagent with DAPI 
(Molecular Probes, Invitrogen) and analyzed with a Zeiss Observer LSM 710 confocal 
scanning microscope.  
 
2.5 BIOFILM RESISTANCE TO ANTIBIOTICS 
To determine the resistance capabilities of planktonic and biofilm cells we used antibiotic of 
choice for CDI treatment, antibiotic vancomycin (Sigma-Aldrich, USA), at 200 times the MIC, 
20μg/ml. Resistance was determined to the both parts of biofilm, sessile and the planktonic 
populations, from the same C. difficile culture. The supernatant (planktonic fraction) from 1 
or 3 day biofilm cultures in 6-well plates was removed, washed once in sterile PBS, re-
suspended in BHIS 0.1M glucose with 20μg/ml vancomycin (Sigma-Aldrich, USA), and 
incubated in fresh 6-well plates. In parallel, to the 6-well plate where supernatants were 
removed, fresh BHIS 0.1M glucose containing 20μg/ml vancomycin was added to the 
adherent biofilms (sessile part). Treatment with vancomycin was performed for 6hrs or 24hrs. 
Colony forming units (CFU) from planktonic and adherent phases were determined by plating 
serial dilutions on BHIS agar. Biofilm cell counts were determined as described above. 
Percent survival was calculated by dividing the number of CFU post-treatment by the initial 
number of CFU. 
To investigate if the protection of bacteria in the biofilm from antibiotic vancomycin is a 
result of biofilm structure (matrix), or is a physiological attribute of the cells in the biofilm, 
we perform experiment as described above, but prior to the incubation with antibiotic we 
disrupted the biofilm matrix. The sessile part of biofilm was disrupted gently by pipetting and 
incubated with BHIS with 0.1M Glc and 20μg/ml vancomycin. The planktonic growth from 
the same well was washed and incubated with BHIS with 0.1M Glc and 20μg/ml vancomycin. 
CFU counts were determined after 6hrs and 24hrs, and counts before and after different times 
of treatment were compared.  
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2.6 INDUCTION OF BIOFILM FORMATION WITH ANTIBIOTICS 
Formation of biofilms can be stimulated by different environmental stresses, including 
antibiotic stress. To investigate if antibiotic could induce biofilm formation, sub-inhibitory 
and inhibitory concentrations of antibiotic vancomycin (sub-inhibitory concentrations 0μg/ml, 
0.05μg/ml, 0.1μg/ml, 0.25μg/ml, and inhibitory concentration 0.5μg/ml) were added to 
biofilm at time point 0. Biofilms were allowed to form in 24-well plate for one and three days, 
followed by staining with 0.2% crystal violet as described above.  
 
2.7 MEASUREMENT OF C. difficile SPORES IN BIOFILM  
C. difficile spores were measured as previously described (Burns et al., 2010). At day 1, 3 and 
5 of biofilm formation samples (separated two biofilms parts, adherent and planktonic part, 
and as a control C. difficile non-biofilm planktonic culture, grown in a tube) were removed 
from the anaerobic chamber and heated at 65°C for 25min to kill the vegetative cells but not 
the spores. Serially diluted were then plated onto BHIS agar and BHIS supplemented with 0.1% 
taurocholate (Sigma-Aldrich, USA) in anaerobic contitions. Bile acid taurocholate stimulates 
the germination of C. difficile spores (Burns et al., 2010). BHIS agar was used as negative 
control, and BHIS supplemented with 0.1% taurocholate was used for germination of spore. 
Plates were incubated for 24hrs to 48hrs at 37°C under anaerobic conditions. As a control, 
total counts of vegetative cells and spores were determined by plating dilutions of untreated 
culture on the same medium. 
 
2.8 SWIMMING ASSAY 
For swimming assay semi-solid 0.3% BHIS agar plates were employed. The plates were 
solidified overnight at room temperature and dried at 37˚C for 60 minutes. Single C. difficile 
colonies on BHIS plates were picked with toothpick and stabbed into the middle of the semi-
solid agar of the motility plates. Plates were incubated for at least 48hrs at 37°C under 
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anaerobic conditions. Plates were not inverted. After incubation photographs of the plates 
were taken.  
 
2.9 GENETIC MANIPULATION OF C. DIFFICILE  
2.9.1 Generation of C. difficile deletion mutants with allelic exchange method 
C. difficile R20291Δcwp84 (Ng et al., 2013) and C. difficile R20291ΔrsbW (this study) were 
generated in R20291 background employing the allele exchange strategy, described by 
Cartman and co-workers (Figure 13) (Cartman et al., 2012). Positions of in frame deletions 
are reported in Appendix 2.  
 
 
Figure 13 Scheme representing the allelelic exchange strategy used to generate deletion mutants in C. 
difficile. 
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Two allele exchange cassettes were cloned into the pMTL-SC7315 vector (Figure 14).  
 
 
Figure 14 Map of pMTL-SC7315 vector for allelic exchange. 
 
Approximately 500 bp fragments of the flanking regions of the target gene were amplified by 
PCR from R20291 genomic DNA (isolated using a DNeasy Blood and Tissue kit, Qiagen). 
Amplification reaction was carried out with Phusion High-Fidelity DNA polymerase (New 
England BioLabs) using the primers couples F1_rsbW and R1_rsbW for amplification of the 
upstream cassette and F2_rsbW and R2_rsbW for amplification of the downstream cassette 
(Appendix 3). Primers have ends containing the appropriate restriction sites for cloning 
(F1_rsbW and R2_rsbW carry a PmeI site, R1_rsbW and F2_rsbW an EcoRI site). 
Thermocycling conditions were 95°C for 5min, followed by 35 cycles of 95°C for 30s, an 
appropriate annealing temperature for 30s, 72°C for 1min/kb, and a final extension of 72°C 
for 10min. The upstream and downstream fragments were cloned into the PmeI site of pMTL-
MATERIALS AND METHODS 
42 
 
SC7315 by one-step ligation with T4 DNA ligase (Rapid DNA Ligation kit, Roche) to 
generate an in-frame deletion in the C. difficile R20291 rsbW open reading frame (deletion of 
nucleotides 10 to 401). The reaction was transformed in the E. coli cloning strain DH5α 
(Invitrogen) by heat shock. Selection of transformants was carried out on LB solid medium 
supplemented with 25μg/ml chloramphenicol. Several colonies were picked and inoculated in 
liquid LB medium supplemented with 12.5μg/ml chloramphenicol. Using standard plasmid 
extraction methods, plasmid was purified from each of the overnight cultures and screened by 
restriction analysis with PmeI and by PCR using primers couple SC7-F1 and SC7-R1 
(Appendix 3). Then the DNA sequence was checked by Sanger sequencing using primers 
SC7-F and SC7-R (Appendix 3). Restriction endonucleases were obtained from New England 
BioLabs and used according to the manufacturer's instructions.  
Knock-out plasmid was transferred into the C. difficile recipient by conjugation. A knockout 
cassette plasmid verified by sequencing was re-transformed into electrocompetent E.coli 
conjugation donor strain CA434, carrying out selection on LB plates supplemented with 
25μg/ml chloramphenicol. Recipient strain C. difficile R20291 and donor strain E. coli 
CA434/pMTL-SC7315-rsbW were grown overnight in BHIS and in LB with 12.5μg/ml 
chloramphenicol, respectively. 1ml of the stationary overnight culture of E. coli donor strain 
was pelleted and washed with 0.5ml PBS. The conjugal donor pellet was then resuspended in 
200μl of stationary overnight culture of conjugal recipient cells and the entire conjugation 
mixture was pipetted onto a single BHIS non-selective plate in discrete drops. After 24hrs of 
incubation under anaerobic conditions (to allow conjugal transfer of the knockout plasmid 
from the E. coli donor to the C. difficile recipient) all growth was harvested into 500μl PBS 
and plated onto BHIS plates containing D-cycloserine (250μg/ml), cefoxitin (8μg/ml) and 
thiamphenicol (15μg/ml) to select for transconjugants (i.e. C. difficile cells harbouring the 
plasmid). Plates were incubated at 37°C under anaerobic conditions for 24-72hrs. Antibiotics 
D-cycloserine and cefoxitin are selection markers for E. coli donor, while thiamphenicol is a 
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selection for C. difficile transconjugants (bacteria with pMTL-SC7315-rsbW plasmid carry 
thiamphenicol cassette, catP).    
Transconjugant colonies were then restreaked and incubated 24-72hrs at 37°C under 
anaerobic conditions. Single cross-over clones were identified as faster growing colonies in 
amongst slower growing transconjugant colonies. In the first cross-over, mutants were 
isolated based on an antibiotic cassette on the pseudo-suicide plasmid, which replicates 
episomally slower that bacterial chromosome, which makes single cross-overs faster growing 
colonies in amongst slower growing transconjugant colonies. Single cross-over clones were 
purified by picking and restreaking, and then confirmed by PCR analysis carried out with 
Platinum Taq (Invitrogen) in Failsafe PCR buffer E (Epicentre), using primers pairs 
RsbW_contr_F and SC7_R and RsbW_cont_R and SC7_R (Appendix 3). 
Single cross-over mutants are unstable, which makes the loss of plasmid easy and efficient, 
once selective antibiotic pressure is removed. To allow rare second recombination events to 
occur, single-crossover clones were restreaked onto nonselective BHIS medium and incubated 
for 96hrs. All growth was harvested in 500μl PBS and serial dilutions were made (from 10-1 
to 10
-6
). 100μl of each dilution were plated onto CDM supplemented with 50μg/ml 5-
fluorocytosine (FC). Second cross-over mutants were isolated using a negative selective 
marker present on the plasmid. After 48hrs of incubation FC-resistant clones were patch 
plated onto BHIS supplemented with cycloserine, cefoxitin, and thiamphenicol, to screen for 
plasmid loss. Fluorocytosine-resistant and thiamphenicol-sensitive clones were analyzed by 
PCR reaction to distinguish double-crossover recombinant clones from wild-type revertant 
clones, using primers F1_rsbW and R2_rsbW (Appendix 3). Sanger sequencing was used to 
confirm the expected genotype.  
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2.9.2 Generation of C. difficile insertion mutants with Clostron method 
Mutants in genes sleC, spo0A and fliC were generated using the insertional inactivation 
system, ClosTron, as previously described (Burns et al., 2010); (Heap et al., 2007); (Baban et 
al., 2013). Positions of ClosTron insertions are reported in Appendix 2. The luxS-gene was 
insertionally inactivated using the ClosTron system as described (Heap et al., 2007); (Heap et 
al., 2010). Plasmid pMTL007C-E2 was retargeted to yield pMTL007C-E2-luxS161a. These 
plasmids were conjugated into R20291 and transconjugants were selected on agar plates 
supplemented with thiamphenicol and cycloserine/cefoxitin. Transconjugants were then 
plated onto lincomycin agar plates to select for integrants. Potential integrants were verified 
by PCR screening and subsequent DNA sequencing using the primers luxS_95_F and 
luxS_262_R.  
 
2.9.3 Construction of C. difficile mutants and complemented strains 
For complementation studies for C. difficile R202911::sleC plasmid pMTL-DB1 (Burns et al., 
2010) was introduced into the mutant, resulting in strain C. difficile R202911::sleC + pMTL-
DB1 (sleC-C). Chromosomal complementation of C. difficile R20291Δcwp84 with cwp84 
was performed as described (Ng et al., 2013) to yield C. difficile R202911Δcwp84-C (cwp84-
C). A 724-bp fragment surrounding the putative luxS structural gene (456-bp) and 5-
noncoding region (268-bp) was amplified by PCR using oligonucleotide primer F1_luxS and 
R1_luxS and cloned using NotI and XhoI into pMTL-84151 (Heap et al., 2009), resulting in 
plasmid pMTL-TD1. This plasmid was conjugated into the luxS mutant C. difficile 
R202911::luxS to yield C. difficile R202911::luxS + pMTL-TD1 (luxS-C). Fragments 
containing the native promoter and full length genes for fliC and spo0A were cloned into 
plasmids pMTL-84151 and pMTL-960, respectively.  The spo0A sequence was amplified by 
PCR using genomic DNA from C. difficile 630Δerm as template and primers Cdi-spo0A-F1 
and Cdi-spo0A-R1. The resulting product comprised the spo0A open reading frame with 174-
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bp of upstream sequence and 205-bp of downstream sequence. This was cloned into the 
pCR2.1-TOPO vector (Invitrogen) and confirmed by sequencing. The spo0A 
complementation construct was subsequently excised as a SpeI/BamHI fragment and cloned 
into similarly digested pMTL960 and conjugate into spo0A mutant C. difficile 
R202911::spo0A to yield C. difficile R202911::spo0A + pMTL960-spo0A (spo0A-C).  
For complementation studies for C. difficile R202911::fliC, a 973-bp fragment encompassing 
the fliC open reading frame (873bp) with the 100-bp 5’ noncoding region most likely 
containing the fliC promoter, was cloned in pMTL-84151 to generate pMTL-SB1(Baban et al., 
2013). Plasmid pMTL-SB1 was introduced into the mutant, resulting in strain C. difficile 
R202911::fliC + pMTL-SB1 (fliC-C). 
 
2.10 SANGER SEQUENCING 
For Sanger sequencing, genomic DNA was isolated (using a DNeasy Blood and Tissue kit, 
Qiagen) from strains R20291, derived from different laboratories. PCR was carried out with 
Platinum Taq (Invitrogen) in Failsafe PCR buffer E (Epicentre), using primers pair rsbW_F 
and rsbW_R (Appendix 3). Sequencing was repeated in at least three independent experiments, 
from three independent isolated genomic DNA preparations.  
 
2.11 STATISTICAL ANALYSES 
All experiments were performed in triplicates and at least three independent experiments were 
performed. A paired Student’s t test was performed to determine if the differences between 
two groups was significant. P values <0.05 were considered statistically significant. 
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3 RESULTS 
3.1 Clostridium difficile BIOFILM FORMATION 
3.1.1 Clostridium difficile forms time and strain dependent biofilms in vitro 
In order to investigate biofilm formation by C. difficile we studied two clinically important 
strains. Stain 630, a commonly studied clinical strain, and strain B1/NAP1/027 R20291, strain 
isolated from the Stoke Mandeville outbreak in 2004 and 2005 in United Kingdom (R20291). 
Formation of the biofilms was measured with different methods: by staining the biofilms with 
crystal violet stain (CV), by preforming colony-forming unit counts (CFU) of sessile and 
planktonic part of the biofilm, and by staining the biofilms with Live/Dead stain and observe 
it under the confocal microscopy.  
In order to obtain optimal conditions for C. difficile biofilm formation we tested biofilm 
formation in several different media (chemically defined minimal media CDMM, and rich 
media BHIS and TYM). Moreover, we supplemented the media with different additives: 
 10mM, 20mM glucose, 40mM and 0.1M glucose 
 0.3M sodium chloride 
 0.1M glucose and 0,3M sodium chloride  
 0.1% and 1.0% Bile salts mixture (Sigma-Aldrich, USA) 
 0.1% Bile salt taurocholate (Sigma-Aldrich, USA) 
 0.1% Bile salt chenodeoxycholate (Sigma-Aldrich, USA) 
 0.1% Bile salt sodium cholate (Sigma-Aldrich, USA) 
 2.5g/L mucin (Sigma-Aldrich, USA) 
We incubated the bacteria in biofilm assay for period from one to five days, in anaerobic 
conditions, at 37C. For the biofilm assay 24- or 48-well cell culture plates were used. To 
observe the biofilms under confocal microscopy, biofilm was allowed to form in 4-well glass 
chamber slides (BD Falcon, USA).  
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Figure 15 C. difficile biofilm formation in vitro. 
Both strains form higher amounts of biofilm in rich medium BHIS supplemented with 0.1M 
glucose. In the absence of glucose, strain 630 forms significantly lower amounts of biofilm as 
compared to biofilm seen in presence of 0.1M glucose. However, the presence of glucose 
does not significantly affect biofilm formation for the strain R20291. Presence of 0.3M 
sodium chloride inhibits biofilm formation in both strains (Figure 15). We were not able to 
observe biofilm formation when used medium CDMM and TYM, or when supplemented with 
a mixture or single bile salts. Biofilms formed were adherent in nature, and were found to 
form only biofilm on the bottom of the wells (of 24-well plate), and not on the surface of the 
culture medium (Figure 15). Biofilm formed by the strain R20291 uniformly covers the entire 
surface area of the bottom of the wells (24-well plate) at 24hrs (day 1), while at the same time 
point for strain 630 we see much lesser biofilm formation. At 72hrs we observe relatively 
more uniform biofilms for strain 630 and uneven biofilms for strain R20291 (Figure 15). 
 
 
 
 
 
 
 
 (A) Biofilm formation by strain 630 and strain R20291, in BHIS supplemented with 0.1M glucose or 0.3M 
NaCl, for 3 days at 37°C in anaerobic conditions. Biofilm formation was measured by crystal violet staining. 
Results are presented in log scale and the error bars represent standard deviations (P<0.05). Data are 
representative of at least three independent experiments, each performed in triplicates. (B) Photographs of 
biofilms formed on a 24 well plate for strains 630 and R20291 on day 1 and day 3 are shown. 
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Biofilm formation in BHIS 0.1M glucose was monitored over a time period from 1hr to 
120hrs (5 days), and quantitated by both, crystal violet staining and colony-forming unit 
counts (CFU) (Figure 16). C. difficile 630 biofilm accumulation appears to be maximal at day 
5 (120hrs) (Figure 16a). Strain R20291 starts to form biofilm after 6hrs of incubation, with 
maximum biofilm formation after 24hrs, as measured by CV staining (Figure 16b). Bacterial 
counts from biofilms indicate a similar trend of increasing bacterial numbers until 24hrs and a 
decrease after this period for both strains. However it is clear that R20291 biofilms have 
significantly higher number of vital bacteria in the biofilm, as well as higher amounts of 
biofilms as quantitated by CV, compared with 630, under the conditions tested (Figure 16). 
 
       
Figure 16 Time course experiment. Biofilm formation for strains 630 (A) and R20291 (B) measured by crystal 
violet staining presented on primary axis (gray line), and colony counts on secondary axis (CFU/ml, black line). 
Results are presented in log scale and the error bars represent standard deviations (P<0.05). Data are 
representative of at least three independent experiments, each performed in triplicates. 
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To examine biofilm formation by strains R20291 and 630 further, biofilms were allowed to 
form on glass slides in BHIS 0.1M glucose for one or three days. Live/Dead staining (Syto 9 
and propidium iodide dyes, staining live bacteria green and dead bacteria red, respectively) 
was employed in order to evaluate the bacterial viability and biofilm thickness. We find that 
the majority of bacteria in both the 630 (Figure 17 a and b) and R20291 (Figure 17 c and d) 
biofilms were alive with a minor number of dead cells after one (Figure 17 a and c) and three 
days (Figure 17 b and d). Z-stack acquisitions revealed multiple layers of bacteria in the 
biofilm underneath a dense layer of material (Figure 17, right panel). 3D images show the 
presence of uniformly spread biofilms for R20291 on day 1 (Figure 17c) and with uneven 
secondary structures by day 3 (Figure 17d), and with a thickness ranging from 30 to 45μm. 
For strain 630, we observe that the live dead staining of biofilms was not homogeneous as 
seen for R20291 after day one (Figure 17 Confocal microscopy analysis of biofilms formed 
by C. difficile.a) or day three (Figure 17b). The maximum thickness of the biofilm was 30μm 
(72hrs). Thus microscopic analysis suggests that C. difficile biofilms are structured, with 
several layers of largely live bacteria encased within a dense matrix. 
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                                                                                                                                Live/dead staining shows dead 
(red) and live (green) bacteria (Syto 9 and propidium iodide dye, respectively) in strains 630 (A, B) and R20291 
(C, D) biofilms after incubation for 1 day (A, C) and 3 days (B, D). 3D images of biofilms depicting biofilm 
thickness in µM are shown in the left panels. 
A 
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D 
   Figure 17 Confocal microscopy analysis of biofilms formed by C. difficile.
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3.1.2 C. difficile biofilm matrix 
Since the R20291 biofilm was more robust and reproducible, we decided that for further 
studies on C. difficile biofilm formation we focused exclusively on this strain, isolated form 
Stoke Mandeville outbreak. To study C. difficile biofilm matrix we used multiple staining to 
evaluate the extra-cellular matrix. Staining with antibodies against whole bacteria was able to 
stain a complex biofilm matrix and just few superficial individual bacteria (Figure 18), 
suggesting that biofilm matrix may be impermeable for the antibody. As a control we stained 
bacteria with preimmune serum (Figure 18, right panel). 
 
 
 
 
 
 
                                                                                                                3D confocal microscopy images are 
presenting stained R20291 biofilm with murine anti-R20291 (left panel), and with mouse preimmune serum 
(right panel), after 3 days incubation. 
 
The formation of a thick mature biofilm was visualized by a biofilm matrix tracer Ruby stain, 
which labels a range of protein classes including glycol-, lipo- and phosphoproteins (Figure 
19). 
 
 
 
 
 
 
Figure 18 Staining with antibody against whole bacteria R20291.
Figure 19 Biofilms stained with Ruby matrix stain after 3 days of incubation. 
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Figure 20 Staining with antibody against synthetic C. difficile PSII polysaccharide. 
As last, we stained the biofilm with antibody against a synthetic C. difficile PSII 
polysaccharide (synthetic phosphorylated hexasaccharide repeating unit) (Adamo et al., 2012). 
Staining of biofilm with antibody against PSII showed presence of fiber-like structures on the 
biofilm (Figure 20a) suggesting bacterial capsule could be involved in biofilm formation. As a 
control we stained bacteria with preimmune serum (Figure 20b). DAPI staining stained 
bacterial DNA. 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                           Biofilms were stained 
with antibodies to a synthetic C. difficile PSII polysaccharide (red) and DAPI (blue), which stains the bacterial 
DNA (A), or with the control mice preimmune serum and DAPI (B). 
 
Biofilm matrix is composed of so called extracellular polymeric substance (EPS). Major 
components of EPS are protein, nucleic acid, and polysaccharides (Flemming and Wingender, 
2010). To confirm that proteins are part of biofilm matrix we treated biofilms with 0.1mg/ml 
proteinase K. While planktonic growth was not inhibited by proteinase K (Figure 21c), 
incubation of the bacterial cultures with the enzyme resulted in a significant inhibition in 
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biofilm formation on days 1 and 3 (Figure 21a, dark bars). To examine if proteinase K can 
also disrupt already formed biofilm, we incubated 1 day-old biofilm with the same enzyme 
(Figure 21a, light bars). Results showed that addition of proteinase K to the preformed biofilm 
caused its disassembly compared to a non-treated control. We also performed similar 
experiments with DNase I treatment, and find that DNase I also inhibits biofilm formation 
(Figure 21b, dark bars), and is able to reduce pre-formed biofilms (Figure 21b, light bars), 
although to a lesser degree as compared to proteinase K. DNase I also did not affected the 
planktonic growth (Figure 21c). 
 
        
Figure 21 Proteins and DNA are part of biofilm matrix. Biofilms were incubated with proteinase K (A) or 
DNase I (B). The dark grey bars represent data from treatment of either enzyme at the start of incubation 
(inhibition of biofilm formation), and the light grey bars represent data from incubating pre-formed 1 day-old 
biofilms with either enzyme (disruption of biofilms). Data shown are representative of at least 2 independent 
experiments performed in triplicates (P<0.05). (C) Growth curves of R20291 in BHI in presence of Proteinase K 
(0.1mg/ml) or DNase I (2U/ml). 
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3.1.3 Genetic analysis  
3.1.3.1 Cysteine protease Cwp84 
Numerous cell surface proteins and surface structures such as flagella and pili have been 
shown to be important for biofilm formation in Gram-positive bacteria. Cwp84 is a key 
surface protease involved in maturation of the S-layer of C. difficile. We compared biofilm 
formation of a strain with a deletion in the cwp84 gene, CdiR20291Δcwp84 (Δcwp84), with 
wild-type (WT), using multiple methods. While there was no defect in planktonic growth 
(Figure 22c), we saw a dramatic decrease in biofilm accumulation for Δcwp84 strain as 
measured by crystal violet staining (Figure 22a). The cwp84 mutant showed a more dramatic 
defect in biofilm formation on day 1, as compared to day 3 and day 5. Microscopic analysis 
showed a single layer of bacteria for Δcwp84 strain (Figure 22b, panel 2) as compared with 
WT (Figure 22b, panel 1). The biofilm defect for Δcwp84 strain was fully complemented by 
restoring the WT gene on the chromosome CdiR20291Δcwp8-C (cwp84-C).  
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Figure 22 Role of S-layer in biofilm formation. (A) Biofilm formation by WT R20291, a Δcwp84 mutant for 
days one, three and five and a complemented strains (Δcwp84-C) for day one in vitro as measured by crystal 
violet staining. (B) Confocal microscopy images of live-dead staining of biofilms formed by the WT, Δcwp84 
and Δcwp84-C. Results are presented in log scale and the error bars represent standard deviations (P<0.05). 
Biofilm assays were performed in triplicates, and data are representative of at least 3 independent experiments. 
(C) Growth curves for Δcwp84 mutant and complemented (Δcwp-C) strains. 
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Figure 23 Role of flagella in biofilm formation. 
3.1.3.2 Flagellin FliC 
To examine the role of flagella, a mutant in the flagellin gene, fliC, CRG3351 (fliC) was 
tested for biofilm formation. We observed a significant decrease in biofilm accumulation for 
the fliC mutant as compared to WT on day 5, but not at earlier times, with crystal violet 
staining (Figure 23a), and microscopic analysis (Figure 23b, panel 2). This was reversed upon 
expressing the FliC protein episomally from its native promoter (fliC-C) (Figure 23a). No 
differences in planktonic growth were observed between these strains (data not shown). 
 
 
 
 
 
 
                                                                      (A) Biofilm formation by WT R20291, fliC mutant (fliC) for 
days one, three and five and complemented strains fliC (fliC-C) for day five in vitro as measured by crystal violet 
staining. (B) Confocal microscopy images of live-dead staining of biofilms formed by the WT and fliC. Results 
are presented in log scale and the error bars represent standard deviations (P<0.05). Biofilm assays were 
performed in triplicates, and data are representative of at least 3 independent experiments. 
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3.1.3.3 Quorum sensing authoinducer LuxS 
Quorum sensing (QS) plays a vital part in biofilm formation, and involvement of quorum 
sensing regulators such as luxS has been demonstrated for various other bacteria (Lombardia 
et al., 2006); (Ohtani et al., 2002); (Vendeville et al., 2005). We tested a mutant of a luxS, 
homologue in C. difficile, by homology to other Gram-positive bacteria. A dramatic defect in 
biofilm formation was observed for the luxS mutant, CRG1183 (luxS), both by crystal violet 
staining (Figure 24a) and by microscopy (Figure 24b, center panel), with no significant 
differences at different times after incubation. Examination of the luxS mutant showed that it 
is unable to form even a bacterial monolayer on glass surface. Biofilm defects of this mutant 
were complemented by episomal expression of the full length gene under the control of the 
native promoter (luxS-C). While the complementation did not completely restore the WT 
phenotype we were able to detect several layers of bacteria for the complemented strain 
(Figure 24b, right panel). Although the growth curves for mutant and complemented strains 
were similar (Figure 24c), it is possible that expressing luxS episomally may be toxic for the 
bacteria, as we observe a smaller colony size for this strain on plates. 
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Figure 24 Potential role for quorum sensing in C. difficile biofilm formation. (A) Biofilm formation by WT 
R20291, putative quorum sensing gene luxS mutant (luxS) and complemented strains (luxS-C) as measured by 
crystal violet. (B) Confocal microscopy analysis of WT, luxS and complemented strain luxS-C. Results are 
presented in log scale and the error bars represent standard deviations (P<0.05). Data from biofilm assays are 
representative of at least 3 independent experiments performed in triplicates. (C) Growth curves for luxS mutants 
and complemented (luxS-C) strains. 
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3.1.3.4 Germination factor SleC 
Biofilm formation and sporulation are well known processes. Their connection has been 
extensively studied in Bacillus spp, and master regulator Spo0A was connected with biofilm 
formation and sporulation (Hamon and Lazazzera, 2001). About the role of Spo0A in C. 
difficile biofilm formation we will talk more in the chapter Regulation of C. difficile biofilm 
formation. SleC is a protein that was recently reported to be specifically involved in 
germination of C. difficile spores (Burns et al., 2010). The sleC mutant is able to form 
biofilm-like structures (Figure 25a), but the biofilm is uneven and the thickness of biofilm 
produced by this strain is never more than 20μm (Figure 25b, right panel). The cellular 
morphology of the bacteria in these biofilms is different to wild-type, and appears to form 
filamentous structures. A biofilm defect of the mutant was complemented by episomal 
expression of gene sleC, (sleC-C) under control of its native promoters (Figure 25a). Mutant 
sleC did not have a defect in planktonic growth (Figure 25c) and was unable to form heat-
resistant colonies in a germination assay, confirming the involvement of SleC in germination 
of C. difficile spores (Figure 25d).  
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Figure 25 Germination proteins affect C. difficile biofilm formation. (A) Biofilm formation by WT R20291, 
sleC mutant (sleC) and complemented sleC mutant (sleC-C) after 3 days. (B) Confocal microscopy analysis of 
WT and sleC mutant. (C) Growth curves for sporulation and germination mutants, spo0A and sleC and 
complemented strains (spo0A-C and sleC-C). (D) Germination assays for sleC mutant. Numbers of colony 
forming units CFU/ml obtained from sporulating cultures, with and without heat treatment of C. difficile R20291, 
sleC and sleC complemented strain (sleC-C) after 48hrs of incubation in on BHI in presence or absence of 
sodium taurocholate (T). Results are presented in log scale and the error bars represent standard deviations 
(P<0.05). Both, biofilm and spore quantitation experiments were performed in triplicates, and data shown are 
representative of at least 3 independent experiments.  
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3.2 EFFECTS OF ANTIBIOTIC VANCOMYCIN ON C. difficile BIOFILMS  
3.2.1 Bacteria in the biofilms are resistant to the vancomycin  
Since biofilms are known to be a means by which bacteria protect themselves from antibiotics, 
we studied if C. difficile biofilms are important in mediating antibiotic resistance. We tested 
the resistance of bacteria in biofilms to the antibiotic vancomycin, which is commonly used 
for the treatment of CDI. In vitro, vancomycin, has excellent activity against C. difficile; a 
MIC of 0.75–2.0μg/ml is sufficient to inhibit 90% of strains (Surawicz and Alexander, 2011). 
Both sessile and planktonic phases, from the same C. difficile biofilm culture, 1 day-old 
(Figure 26a) and 3 day-old biofilms (Figure 26b) were exposed to 20μg/ml vancomycin (200 
times the MIC of strain R20291, MIC determinate in our conditions) for 6hrs and 24hrs.  
 
 
 
Figure 26 Antibiotic resistance of C. difficile biofilms. Clostridium difficile 1-day-old (A) to 3-day-old (B) 
biofilms, and the corresponding planktonic growth, were exposed to 20μg/ml vancomycin (200 times the MIC) 
for 6hrs and 24hrs. CFU counts before (untreated) and after (6hrs and 24hrs) treatment with vancomycin are 
shown. Results are presented in log scale and are representative of results from 3 independent experiments, 
performed in triplicates (P<0.05). 
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The percentage of surviving bacteria after treatment with antibiotics for 24hrs for 1 day and 3 
day old biofilms is presented in Figure 27. Bacteria in 1 day-old and 3 day-old biofilms 
survived 5 fold and 12 fold more respectively as compared to planktonic bacteria. These data 
support a role for C. difficile biofilms in resisting antibiotics. 
 
Figure 27 Effect of antibiotics on C. difficile biofilms. Clostridium difficile 1-day-old to 3-day-old biofilms 
and the corresponding planktonic growth were exposed to 20μg/ml vancomycin (200 times the MIC) for 24hrs. 
Data are presented as percentage of surviving bacteria after treatment with antibiotics for 24hrs for 1 day and 3 
day biofilms. Results are presented in log scale and the error bars represent standard deviations (P<0.05). 
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3.2.2 Biofilm matrix protects bacteria from the vancomycin 
Different mechanism can be responsible for the resistance of the bacteria to the antibiotics in 
the biofilms. To try to understand if the resistance to the vancomycin in case of C. difficile 
biofilms is due to protection conferred by biofilm matrix structure, or is an inherent property 
of the bacteria in biofilm, we studied the effect of vancomycin on adherent biofilms which 
were disrupted by pipetting (Figure 28). Disrupted sessile biofilm and the planktonic phase 
from one-day old biofilm were incubated for 6hrs and 24hrs with 20μg/ml vancomycin. 
Bacteria from the disrupted adherent biofilms were not more resistant to high concentrations 
of antibiotics of biofilm compared with bacteria from the planktonic phase (Figure 28). 
Although the bacteria from disrupted biofilms do not form new adherent biofilms after the 
incubation with antibiotics, we observed unstable, thread-like structures in the wells (which 
were disrupted by pipetting before performing CFU counts). These data indicate a lack of 
genetic changes in the bacteria within biofilms, and may suggest that the biofilm matrix, 
and/or other epigenetic mechanisms are involved in mediating vancomycin resistance. 
 
Figure 28 Biofilm matrix protects the bacteria. Clostridium difficile 1-day-old biofilms were disrupted by 
pipetting. Disrupted biofilm and the corresponding planktonic growth were exposed to 20μg/ml vancomycin 
(200 times the MIC) for 6hrs and 24hrs. Data are presented as percentage of surviving bacteria after treatment 
with antibiotics for 6hrs and 24hrs for 1 day old biofilms. Results are presented in log scale and the error bars 
represent standard deviations (P<0.05). 
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3.2.3 Subinhibitory and inhibitory conentrations of vancomyin induce biofilm formation 
Biofilm formation is a common response to the stress conditions, e.g. environmental stresses, 
starvation, and exposure to low concentrations of antibiotics. It has been reported that sub-
inhibitory concentrations of antibiotics can stimulate biofilm formation (Hoffman et al., 2005). 
To study if vancomycin stimulates the biofilm formation in vitro, bacteria were treated with a 
range of concentrations of vancomycin (0 – 0.5μg/ml), both lower and higher than the tube 
growth MIC (0.2µg/ml) and biofilm formation was measured at day 1 and day 3. No 
significant induction of biofilm was observed for any of the vancomycin concentrations after 
1 day. Inhibition of biofilm formation was evident for concentrations of vancomycin 0.5µg/ml 
and higher (Figure 29). Interestingly, after 3 days incubation, a significant induction of 
biofilms was observed with 0.5µg/ml vancomycin and to a lesser extent with a sub-inhibitory 
concentration (0.25µg/ml) of vancomycin (Figure 29). These results suggest that exposure to 
sub-inhibitory and inhibitory concentrations of vancomycin can stimulate biofilm formation 
in vitro. 
 
Figure 29 Sub-inhibitory and inhibitory concentrations of antibiotic stimulate biofilm formation by C. 
difficile. Biofilm formation measured by crystal violet staining at day 1 and day 3 after treatment with sub-
inhibitory and inhibitory concentration of antibiotic vancomycin (MIC for R20291 was 0.2µg/ml). Results are 
presented in log scale and the error bars represent standard deviations (P<0.05). * denotes significant differences 
as compared with biofilm formation in absence of vancomycin (0µg/ml). 
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3.3 REGULATION OF C. difficile BIOFILM FORMATION 
3.3.1 Master regulator Spo0A 
3.3.1.1 Spores in C. difficile biofilms 
Sporulation it is a key pathway that is initiated when C. difficile is under stress conditions. 
Regulators of sporulation like Spo0A are also involved in formation of biofilms in other 
Gram-positive bacteria (Hamon and Lazazzera, 2001). We first studied if spore formation 
occurs in C. difficile biofilms in our growth conditions, for adherent biofilms and planktonic 
phase from the same well of the 24-well plate (Figure 30a). We found that there are very few 
spores in the biofilm (0.0001%) and in planktonic phases (none detectable) on day 3 and day 
5. However, in the control, which was bacteria cultured in a tube (where biofilm formation 
did not occur) spores were formed by day 3 (40-50%) (Figure 30a). We also confirmed that a 
spo0A mutant is defective in sporulation (Figure 30b).  
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Figure 30 Sporulation in C. difficile biofilms. (A) Quantitation of the number of spores present in the adherent, 
planktonic phases of biofilm and in planktonic tube culture, in brain heart infusion media (BHI) with sodium 
taurocholate (BHI+T) and heat treatment (65⁰C). (B) Germination assays for spo0A. Numbers of colony forming 
units CFU/ml obtained from sporulating cultures, with and without heat treatment of C. difficile R20291, spo0A 
and spo0A complemented strain (spo0A-C) after 48hrs of incubation in on BHI in presence or absence of sodium 
taurocholate (T). Results are presented in log scale and the error bars represent standard deviations (P<0.05).  
Experiments were performed in triplicates, and data shown are representative of at least 3 independent 
experiments. 
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3.3.1.2 Mutant in spo0A is unable to form biofilm in vitro conditions 
Master regulator Spo0A is a central transcriptional regulator, which controls the expression of 
more than 100 genes, including genes for biofilm matrix expression and sporulation (Fujita et 
al., 2005); (Molle et al., 2003). Concentration of phosphorylated or unphosphorylated forms 
of Spo0A (Spo0A~P) determines gene expression. Both forms, phosphorylated and 
unphosphorylated form, are always present in the cell. Intermediate levels of Spo0A~P induce 
matrix gene expression and with it biofilm formation, and higher levels induce the sporulation 
in the bacterium B. subtilis. With maturation of the biofilm, and accumulation of Spo0A~P in 
the cell and the process of sporulation is activated (Vlamakis et al., 2013). 
We demonstrated that the mutant in spo0A, which was unable to sporulate (Figure 30b), forms 
significantly less biofilm compared with WT both by CV staining (Figure 31a) and 
microscopy (Figure 31b, panel 2). This phenotype was restored by episomal expression of 
genes spo0A (spoA-C) under control of its native promoters (Figure 31). 
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                                                                                                                 (A) Biofilm formation by WT R20291, 
sporulation transcription factor spo0A mutant (spo0A) and complemented spo0A mutant (spo0A-C) after 1 day. 
(B) Confocal microscopy analysis of WT and mutants spo0A and complemented spo0A mutant (spo0A-C). 
Results are presented in log scale and the error bars represent standard deviations (P<0.05). Both biofilm and 
spore quantitation experiments were performed in triplicates, and data shown are representative of at least 3 
independent experiments. 
 
Our results indicate that Spo0A could have a similar role in C. difficile as it has in B. subtilis. 
We were unable to detect significant number of spores in the biofilms in the R20291 strain 
under our culture conditions, while the mutant in spo0A was defective in its ability to form 
biofilm. This could indicate that the intermediate levels of Spo0A~P are present in the cells, 
which induces matrix gene expression and with it biofilm formation. 
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Figure 31 Sporulation protein affect C. difficile biofilm formation. 
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3.3.1.3 Inhibitory concentrations of vancomyicin restore biofilm formation in spo0A mutant   
Regulation of biofilm formation through the master regulator Spo0A is the best studied 
biofilm pathway in B. subtilis, but not the only one (Vlamakis et al., 2013). Several different 
pathways for biofilm formation are Spo0A-independent. The abh gene transcription is 
controlled by several extracytoplasmic function (ECF) RNA polymerase σ-factors, including 
σM, σW and σX, which are are activated by enviromental stimuli, e.g. cell wall stress and 
specific antibiotics stresses (Helmann, 2002). Abh can indirectly repress the repressor SinR, 
which leads to the transcription of biofilm matrix genes. In this way the bacterium can 
respond to enviromental changes in a Spo0A-independent way (Vlamakis et al., 2013).   
To study potential Spo0A-independent pathways in C. difficile biofilm formation we 
incubated the mutant spo0A (which was unable to form biofilm) with sub-inhibitory and 
inhibitory concentrations of antibiotic vancomycin (MIC for spo0A mutant was 0.5µg/mL). 
Inhibitory concentration of vancomycin, 1.0µg/mL, was able to restore the biofilm formation 
to a wild-type R20291 level (Figure 32). This indicates that the regulation of C. difficile 
biofilm formation is a complex, and as in case of B. subtilis, biofilm formation may be subject 
to several layers of regulation, including Spo0A-independent pathways. 
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Figure 32 Spo0A-independent biofilm formation. Mutant spo0A, which is unable to form biofilm in normal 
conditions, was complemented with addition of inhibitory concentrations of antibiotic vancomycin (1.0µg/mL). 
Mutant spo0A, supplemented with antibiotic vancomyicin, was able to form biofilms comparable with the wild-
type, R20291.  
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3.3.2 Anti sigma-factor RsbW 
3.3.2.1 Single-nucleotide polymorphism (SNP) in C. difficile 
Many contradictions within studies on Clostridium difficile can be found in the literature. 
Recently, two different stories, based on similar experiments and animal models, were 
published. Lyras and co-authors published in Nature Letters (2009) results showing that only 
toxin B is essential for the pathogenesis of C. difficile (Lyras et al., 2009). Just a year later 
(2010), Kuehne and co-authors published that toxin A and toxin B are both needed for the 
pathogenesis by C. difficile (Kuehne et al., 2010).  
In our initial studies we found that clinical C. difficile strains, originally coming from the 
same out-break, but stored in different laboratories around United Kingdom, showed 
differences in biofilm formation, sporulation, minimal inhibitory concentration to the 
antibiotic vancomycin, and motility. 
Whole genome sequencing was performed in collaboration with Nigel Minton laboratory, 
from University of Nottingham, Clostridia research group (CRG). Sequences of these strains 
showed the presence of single nucleoide polymorphisms (SNPs) in different regulatory genes. 
The strain, in which we performed our previous studies, carries a SNP in the anti-sigma factor 
RsbW and in the gene vncR.  
SNP for the gene rsbW, detected with whole genome sequencing, was confirmed with Sanger 
sequencing with the primers rsbW_F and rsb_R (Appendix 3).  Nucleotide in the position 245 
changed from a nucleotide ‘G’ to a nucleotide ‘T’, compared to a reference genome R20291. 
The SNP is a nonsynonymous mutation in the genome, and caused a change in amino acid 
sequence, changing a glycine to valine.  
RsbW is an anti-sigma factor which regulates the stress response induced by alternative sigma 
factor (σB). As its role in biofilm formation was previously shown in other bacteria, e.g. 
Staphylococcus epidermidis (Knobloch et al., 2004), we investigated the potential role of this 
regulator in biofilm formation by C. difficile. 
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1488bp ˗˗˗ 
1143bp ˗˗˗ 
 
3.3.2.2 Characterization of role of rsbW in biofilms  
3.3.2.2.1 Generation of a ΔrsbW deletion mutant in R20291 background  
To investigate the function of anti-sigma factor RsbW, and the effect of the SNP in this gene, 
a deletion mutant was generated in strain R20291 strain that lacks SNP in rsbW, taking 
advantage of an allele exchange strategy set up by Cartman and co-workers (Cartman et al., 
2012). 
A suitable construct was generated cloning “in frame”, in the pMTL-SC7315 vector (Cartman 
et al., 2012), the two regions flanking the gene of interest, in order to substitute the functional 
endogenous gene with a short sequence coding for a non-functional short peptide. The 
construct was transformed in C. difficile, where two steps of selection where carried out, as 
described in Methods. First, clones which had integrated the entire plasmid were selected for 
antibiotic resistance and checked by PCR (data not shown); then, clones which had undergone 
excision of the plasmid (resulting either in deletion of the gene or in recovery of the wild-type 
genotype) were positively selected on fluorocytosin and the genotype (wild-type or deletion 
mutant) was determined by PCR (Figure 33). Abolishment of the expression of the gene rsbW 
in a deletion mutant, the expression of the gene sigB, which is upstream of rsbW, and 
predicted gene rsbV, which is downstream, were checked by qRT PCR (data not shown). 
 
 
Figure 33 PCR selection of R20291ΔrsbW deletion mutant. Primers external to the rsbW coding sequence 
were used. Expected molecular weight is 1488 bp for the wild-type, 1143 bp for the deletion mutant. Lines: 1 – 
marker; 2 – R20291; 3 – R20291ΔrsbW; 4 – R20291_SNP; 5 – negative control.   
        1         2        3        4        5 
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3.3.2.2.2 Tracking bacterial growth and biofilm formation 
We compared biofilm formation between three strains, wild-type R20291 without the SNP in 
rsbW (R20291), strain with a clean deletion in the gene rsbW (R20291ΔrsbW), and R20291 
strain with the SNP in gene rsbW (R20291_SNP). In time course experiment mutants 
R20291ΔrsbW and R20291_SNP formed significantly more biofilm compared to wild-type 
strain (Figure 34a). Growth curve showed that strain R20291_SNP has a growth defect when 
grown in liquid BHIS (Figure 34b). When we preformed CFU counts on biofilm culture 
(sessile and planktonic part of biofilm together) we did not observe any significant difference 
at day one, however, at day three and five we observed a significant drop in CFU for the 
mutant R20291ΔrsbW (Figure 34c). This result suggests that even though the strain with the 
SNP in rsbW has a defect in growth in liquid media, this does not affect biofilm formation. 
And the drop in number of vital, colony forming, bacteria in biofilm culture in the strain 
R20291ΔrsbW does not cause a reduction of biofilms, which could suggest that majority of 
biomass in R20291ΔrsbW is composed from biofilm matrix, and not vital bacteria.  
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Figure 34 Role of the anti-sigma factor RsbW in biofilm formation and in bacterial growth. (A) Wild-type 
strain R20291, which has an active anti-sigma factor RsbW, forms significant less biofilm compared with strain 
with deleted rsbW strain R20291ΔrsbW and strain with a SNP in rsbW, R20291_SNP at days one, three and five. 
(B) Strain with the SNP in rsbW, R20291_SNP, has a defect in growth in a liquid medium, but not the strains 
R20291 or R20291ΔrsbW. (C) CFU counts showed decreased numbers of vital, colony forming bacteria, for the 
strain R20291ΔrsbW in the biofilm at the days three and five.   
0
1
2
3
4
5
6
1 2 3 4 5 6 7 8 9 10
O
D
6
0
0
 
R20291
R20291ΔrsbW 
R20291_SNP
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
1.00E+08
1.00E+09
1.00E+10
B 
* 
* * * 
RESULTS 
76 
 
3.3.2.2.3 Confocal microscopy 
To visually characterize biofilm, evaluate the bacterial viability, and biofilm thickness, we 
stained biofilm formed on culture slides with Live/Dead stain for all three strains, wild-type 
R20291 and two strains with a mutation in gene rsbW. Live/Dead stain is composed of Syto 9 
dye, which stains live bacteria green, and propidium iodide dye, which stains dead bacteria 
red. Wild-type strain R20291 forms an ununiformed biofilm at day one, three and five (Figure 
35, top panel). Biofilm thickness increases with time, and we can detect live (green) and dead 
(red) bacteria at all-time points. Mutant with deleted gene rsbW (R20291ΔrsbW) forms a thick 
and dense biofilm at day one, three and five (Figure 35, center panel). Unlike the biofilm 
formed by the wild-type R20291, biofilm by R20291ΔrsbW is composed of mostly dead 
bacteria at the day three and five, as majority of the bacteria is stained red by propidium 
iodide. This result confirms our data observed with CFU counts (Figure 34c), where we 
detected a drop in the number of vital colony forming bacteria in R20291ΔrsbW biofilms. 
Strain with a SNP in the gene rsbW, R20291_SNP, forms a similar structured biofilm as a 
mutant R20291ΔrsbW. Biofilm formed by R20291_SNP is thick and dense at all-time points, 
and forms 3D structures from day one, with well-structured 3D biofilm at the day five (Figure 
35, bottom panel). The main difference in the biofilms between R20291ΔrsbW and 
R20291_SNP is that the strain with a SNP, but not the strain with a deleted rsbW, is 
composed of mostly live bacteria even at day five (majority of bacteria is stained green). 
These results suggest that anti-sigma factor RsbW has a role in biofilm formation.     
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            Day 1                                           Day 3                                        Day 5 
 
  
 
 
Figure 35 Confocal microscopy analysis biofilms formed by wild-type and rsbW mutant . Biofilms formed 
by wild-type strain R20291 (top panel), strain with a deletion in gene rsbW (middle panel) and strain with a SNP 
in rsbW gene, R20291_SNP (bottom panel) were evaluated for bacterial viability and biofilm thickness. Wild-
type strain R20291 (top panel) forms an  non uniform biofilm at all days, with the biofilm thickness increasing 
with the time. We can detect live (green) and dead (red) bacteria at all-time points. Mutant R20291ΔrsbW 
(middle panel) forms a thick and dense biofilm at day one, three and five, but majority of bacteria is dead at the 
day three and five. R20291_SNP (bottom panel) forms a structured, thick and dense biofilm at all-time points. 
3D structures begin forming from day one.   
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3.3.2.2.4 Sporulation 
We measured the germination of heat treated cultures in liquid culture and from the biofilms. 
We examined cultures over a period of 5 days (presented data for day one old culture, Figure 
36). Initial CFU numbers for all three strains were comparable before the heat treatment (for 
the biofilm culture and culture in planktonic growth). After the heat treatment the wild-type 
strain R20291 formed significantly more colonies on BHIS supplemented with taurocholate in 
the liquid culture and in the biofilms over a period of 5 days compared with strains 
R20291ΔrsbW and R20291_SNP. Strains with the mutation in the gene rsbW formed 
significantly less colonies after the heat treatment. Our data are showing that rsbW mutants 
form significantly more biofilm in vitro compared to the wild-type, but are unable to form 
spores. This could additionally support our hypothesis that the master regulator Spo0A has a 
role in biofilm formation. Anti-sigma factor could indirectly regulate the concentration of 
Spo0A~P present in the cell, likely affecting the kinases responsible for the phosporylation of 
Spo0A.    
 
Figure 36 Sporulation in C. difficile rsbW mutants. Quantitation of the number of spores present in the 
biofilms (BF) and in planktonic tube culture (Planktonic). Heat treated cultures (BF HT and Planktonic HT) were 
plated on brain heart infusion plates (BHIS), supplemented with sodium taurocholate. Results are presented in 
log scale and the error bars represent standard deviations (P<0.05). Experiments were performed in triplicates, 
and data shown are representative of at least 3 independent experiments. 
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1.4 cm 
3.3.2.2.5 Motility  
Recently two different groups in United Kingdom published studies where they examined 
wild-type R20291 with transmission electron microscope (TEM). In work described by 
Martin et al. (Martin et al., 2013) on the surface of the strain R20291 many flagella structures 
were present. When the same strain was exanimated with TEM by Baban and co-authors 
(Baban et al., 2013), just one flagella was present on the bacterial surface.  
We performed a motility assay in low-medium agar with strains R20291, R20291ΔrsbW and 
R20291_SNP. Indeed, wild-type strain R20291 was more motile compared to R20291ΔrsbW 
and R20291_SNP in a low-agar medium. Strains R20291ΔrsbW and R20291_SNP 
demonstrated a defect in motility in vitro (Figure 37). This could suggest presence of different 
number of flagella present on the bacterial surface. Sigma factor B, and hence rsbW, could be 
involved in regulation of assembly of flagella.   
 
                
                          R20291                        R20291ΔrsbW                    R20291_SNP 
Figure 37 Motility assay C. difficile rsbW mutants. Strains with a mutation in a gene rsbW showed to be less 
motile compared to the wild-type R20291.  
 
 
 
 
 
RESULTS 
80 
 
3.3.2.2.6 Complementation of rsbW mutants 
Our results indicate that rsbW is a key regulator for biofilm formation and sporulation, and 
may suggest the SNP in rsbW gene could result in loss of function of anti-sigma factor RsbW. 
To confirm out results we tried to complement the strains R20291ΔrsbW and R20291_SNP 
with an episomal plasmid overexpressing gene rsbW without the SNP, and in parallel with an 
episomal plasmid overexpressing gene rsbW with the SNP. We were able to introduce both 
forms of plasmid in the wild-type strain R20291, but we were unsuccessful in introducing the 
plasmid with wild-type gene rsbW in both mutants. Although our attempts to episomally 
complement the rsbW mutant failed, we were able to introduce plasmid carrying gene rsbW 
with the SNP, which could suggest that unsuccessful complementation is due to potential 
toxicity of the overexpressed regulator in rsbW mutants.  
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4 DISCUSSION 
 
Clostridium difficile is a spore-forming, Gram-positive anaerobic bacillus which can cause 
severe gastrointestinal infections in humans (Rupnik et al., 2009). C. difficile infection (CDI), 
one of the predominant nosocomial infections worldwide, usually occurs when the normal 
intestinal flora is damaged or absent, commonly after the use of antibiotics. The clinical 
symptoms can range from mild or severe diarrhea to serious inflammatory conditions, 
including pseudomembranous colitis (Rupnik et al., 2009). Recently it was demonstrated that 
transmission of clostridial disease occurs through spores (Lawley et al., 2009); (Deakin et al., 
2012). The best-characterized virulence factors of C. difficile are two large clostridial toxins, 
toxin A (TcdA) and B (TcdB) (Kuehne et al., 2010); (Lyras et al., 2009); (Voth and Ballard, 
2005). C. difficile toxins cause disorganization of the cell actin cytoskeleton and tight 
junctions, induction of apoptosis, fluid accumulation, and destruction of the epithelium (Voth 
and Ballard, 2005). Although the toxins are crucial for virulence, in recent years, attention has 
been focused on bacterial colonization of the gut, especially due to increased instances of 
recurrent CDI.  
 
For several pathogens recurrent infections have been associated with the ability to form 
sessile surface-associated microbial communities or ‘biofilms’ (Romling and Balsalobre, 
2012). Bacteria within biofilms are protected and more resistant to different environmental 
stresses, like antibiotic or oxygen stress (Davey and O'Toole G, 2000). Common diseases as 
dental caries and periodontitis are caused by bacteria in biofilms, and biofilm formation has 
been connected with persistent tissue infections such as chronic otitis media, chronic 
rhinosinositis, recurrent urinary tract infections, endocarditis and cystic fibrosis-associated 
lung infections (Costerton, 1999). Recently, biofilms were also associated with chronic 
inflammatory diseases as Crohn’s disease (Claret et al., 2007) and acute infections (Hannan et 
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al., 2012); (Kumagai et al., 2011). Moreover, biofilms represent a big problem when formed 
on artificial devices used in medicine, as catheters, stents, orthopaedic implants, contact 
lenses and implantable electronic devices (Costerton, 1999); (Probert and Gibson, 2002). 
Resistance of bacteria within biofilms to antimicrobials makes treatment of the disease 
difficult and unsuccessful. Furthermore, mature biofilms are highly resilient to the action of 
the innate and adaptive immune defense systems (Hannan et al., 2012). Biofilms are the most 
representative form of growth of bacteria in the large intestine (Macfarlane and Dillon, 2007), 
but the biofilm formation by individual gut species, particularly anaerobic species, has not 
been well characterized. Ability to form biofilms is known to influence virulence and also 
transmission of intestinal pathogenic bacteria such as Vibrio cholera (Faruque et al., 2006); 
(Watnick et al., 2001); (Zhu and Mekalanos, 2003). In addition to spore formation, a known 
means of adaptation to stress, it is likely that C. difficile forms microcolonies in vivo to 
survive the unfavorable environment of the human gut. As biofilm formation by C. difficile, 
especially clinically important strains, was not previously characterized, we sought to develop 
in vitro assays to study C. difficile biofilm formation.  
 
Our study was a first report of the ability of two clinically relevant C. difficile strains, 
laboratory strain 630 and strain isolated from Stoke Mandeville outbreak in 2004 and 2005, 
R20291, to form structured biofilms in vitro (Đapa et al., 2013). The ability to adhere and 
form biofilms influences the ability of pathogens to colonize and establish an infection 
(Allsopp et al., 2010); (Nobbs et al., 2009). We employed multiple techniques (confocal 
microscopy, crystal violet (CV) assay and CFU counts) to demonstrate and quantitate biofilms. 
Our data show that both the R20291 strains we studied form more biofilm in all tested 
conditions in vitro. It has been reported that strain R20291, a strain isolated in an outbreak, 
produces higher levels of toxin in vitro compared to 630 (Warny et al., 2005). Although 
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colonization of these strains has yet to be examined carefully in vivo, higher biofilm formation 
by this strain could indicate better colonization in vivo.  
While for the strain R20291 addition of glucose does not increase the levels of biofilm 
formation, it is an important factor for biofilm formation for strain 630. It is well known that 
different carbohydrates can modulate biofilm formation. Carbohydrates induce biofilm 
formation in Streptococcus gordonii (Gilmore et al., 2003) while in Bacillus subtilis the CcpA 
protein represses formation of biofilm in medium with high levels of glucose (Stanley et al., 
2003). It is possible that in vivo the nutritional environment in the gut modulates colonization 
of C. difficile.  
While the strain R20291 forms maximum biofilm after incubation for 1 day by CV assays and 
CFU counts, strain 630 has the highest number of CFU on day 1, but when stained with CV 
shows the maximum biofilm on day 5. This suggests that strain 630 behaves differently to 
R20291, and may accumulate more biofilm matrix upon longer incubation. These in vitro data 
indicate that the strains may have different behaviors in vivo in terms of biofilm or 
microcolony formation, which may in turn influence their abilities to persist in the gut. 
 
The self-produced biofilm matrix is known to protect bacteria during infections by providing 
an enclosed environment to escape immune responses (Beloin et al., 2008); (Lawley et al., 
2009). Biofilm matrices are typically made up of extracellular polymeric substance (EPS), 
which comprises primarily of proteins, DNA and polysaccharide (Colvin et al., 2011); (Mann 
et al., 2009); (Mann and Wozniak, 2012). Similar to many clinically relevant biofilm formers 
bacteria, such as Pseudomonas aeruginosa and S. aureus, C. difficile also appears to form a 
complex matrix comprising of proteins, DNA and polysaccharide.  
When C. difficile R20291 was stained with antibody against total bacteria we observed a 
complex biofilm matrix with just few stained individual bacteria. This suggested that the 
compact biofilm may comprise surface-associated or secreted bacterial components and may 
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be impenetrable to antibodies. Proteinase K and DNase I treatments inhibited the formation of 
biofilms and caused disassembly of pre-formed biofilms. This further showed that proteins as 
well as external DNA are part of the biofilm matrix. Furthermore, it is interesting that we 
observe biofilm matrix staining for a synthetic derivative of the C. difficile surface PSII 
polysaccharide. Staining with synthetic polysaccharide derivative, which was recently 
reported to be immunogenic (Adamo et al., 2012), revealed the presence of polysaccharide 
components in the biofilm matrix.  
Presence of a complex and perhaps impermeable matrix may protect C. difficile from 
unfavorable agents in vivo in the gut. In all, the data clearly show that C. difficile biofilms are 
composed of a thick multi-component biofilm matrix. Biofilm impenetrability has been 
proposed as a feature of bacterial biofilms that contributes to escape of immune responses 
during the infection, as well as antibiotic resistance in vivo (Beloin et al., 2008); (Watnick et 
al., 2001). 
 
The relevance of biofilm formation in the context of infection and treatment has been widely 
studied. One of the main functions of a biofilm is to protect bacteria within from unfavourable 
conditions such as antibiotics, particularly during infection. The rising incidence of resistance 
to antibiotics treatments for nosocomial pathogens like S. aureus and C. difficile has been well 
documented in recent years (French, 2010), and the role the bacterial biofilms play in resisting 
resistance to the antibiotics has been well demonstrated for many pathogenic species e.g., 
methicillin-resistant S. aureus (Olson et al., 2011). Resistance to antibiotics in biofilm can 
increase from 10- to 1,000-fold more compared to planktonic bacteria (Mann et al., 2009). 
Moreover, highly antibiotic-resistant C. difficile strains and treatment of recurring clostridial 
infections have been the major challenges for managing CDI (Surawicz and Alexander, 2011). 
On the other hand, antibiotics at minimal concentrations could also act as stress signals and 
biofilm formation can be a defensive reaction to the presence of antibiotics, as shown for 
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Gram negative bacteria Escherichia coli and Pseudomonas aeruginosa (Boehm et al., 2009); 
(Hoffman et al., 2005). Induction of biofilms in presence of sub-inhibitory concentrations of 
antibiotics has been previously attributed to alterations in the level of c-di-GMP (Hoffman et 
al., 2005). Such induction in vivo could be clinically relevant when there is exposure to low 
doses of antibiotics, like at the beginning or end of antibiotic therapy, which could perhaps 
explain ineffective treatment (Boehm et al., 2009). In CDI, the establishment of persistent 
biofilms in vivo, in addition to the formation of spores, could potentially explain the 
occurrence of recurrent infections. 
We examined effects of a range of concentration of vancomycin, an antibiotic used for 
treatment of C. difficile infections. Bacteria within biofilms were found to be more resistant to 
high concentrations of vancomycin and C. difficile biofilm formation was induced when 
bacteria were exposed to sub-inhibitory and inhibitory concentrations of vancomycin. Thus, in 
the case of C. difficile, biofilms may have multiple roles depending on the antibiotic 
concentrations in the environment. 
Several mechanisms are known to mediate antibiotic resistance of bacteria within biofilms. 
The biofilm matrix, a main player, can act as an initial physical barrier that can affect 
penetration of the antimicrobial agents (Mah and O'Toole, 2001), while other more complex 
attributes such as the physiological state of the bacterium, like the presence of persistent cells 
in population, can also contribute to resistance (Shah et al., 2006). Biofilm matrix has the role 
of a protective barrier within which bacteria are more tolerant to antibiotics. Concentration 
gradients are formed across the biofilm matrix decreasing the effective concentration of 
antibiotics reaching the bacteria within (Mah and O'Toole, 2001). Persistent cells are 
phenotypic variants of the wild-type in a dormant state and are more resistant to the 
antibiotics. Upon re-inoculation, the persistent bacteria display similar level of tolerance to 
antibiotics (Keren et al., 2004). Indeed, genetic mutations could also occur at low frequencies 
within bacteria in biofilm environments, contributing to antibiotic resistance (Tyerman et al., 
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2013). Genetic changes mediated by systems such as stress responses and slow growth could 
be responsible for the increased tolerance to the antibiotics (Mah and O'Toole, 2001). In our 
initial studies on the mechanism involved in vancomycin resistance, we disrupted biofilms 
and treated with antibiotics. These bacteria were not resistant to vancomycin anymore, 
indicating that vancomycin resistance does not involve genetic or inherited changes in the 
bacteria. As seen in other bacterial species, our data indicate that antibiotic resistance of 
clostridial biofilms may be mediated by the thick biofilm matrix and/or the physiological state 
of bacteria within biofilms (Lewis, 2008). Clearly, much remains to be understood with 
regard to how clostridial biofilms may resistant antibiotics. 
 
Regulation of biofilm formation in Gram-positive bacteria involves multiple factors including 
adhesins, surface structures e.g. flagella and pili (Abee et al., 2011). The C. difficile S-layer is 
composed of S-layer proteins (SLPs) that are present as heterodimeric complex (Fagan et al., 
2009). The signal peptide of protein precursor SlpA is removed by proteolytic cleavage. 
Additional cleavage is essential for maturation of SLPs, which is mediated by the cysteine 
protease Cwp84 (Calabi et al., 2001); (Kirby et al., 2009). A mutant in cwp84 has previously 
been shown to be defective in the S-layer synthesis (Kirby et al., 2009). This protease is also 
important for degradation of extracellular matrix proteins like fibronectin, laminin and 
vitronectin (Janoir et al., 2007). A mutant in cwp84, which shows similar growth rates as 
wild-type in broth culture, is unable to form biofilm, indicating that a mature S-layer, which 
also hosts several other CWPs, is needed for C. difficile biofilm formation. Our data prove 
that a mature S-layer is essential for C. difficile biofilm formation, perhaps due to the fact that 
this layer may be essential for anchoring various cell wall associated proteins, which may be 
required for the early steps such as adhesion during biofilm formation. A role for specific 
CWPs in biofilms remains to be investigated. Furthermore, the observation that antibodies 
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raised against fixed whole bacteria recognize complex structures on biofilms may indicate 
that surface components such as CWPs may compose the biofilm matrix. 
Bacterial flagella are known to modulate attachment, the first step in biofilm formation in 
motile bacteria, however the role of flagella in biofilm development by motile bacteria varies 
between species (Kobayashi, 2007b); (Lemon et al., 2010). For Gram-positive bacteria like B. 
subtilis the presence of flagella is important, but not essential for formation of biofilms 
(Kobayashi, 2007b), while for Listeria monocytogenes, motility is essential for mature biofilm 
formation (Lemon et al., 2010). In our experiments a mutant in flagellin, a principal 
component of flagella, clearly affects biofilms in vitro, indicating that motility of C. difficile is 
key in formation of biofilms. Recently strain 630 C. difficile flagellar mutants were reported 
to have better adherence in an in vitro model (Dingle et al., 2011). Our data further suggest 
that flagella are important at later biofilm stages, as the mutant does not display defects in in 
vitro assays at earlier time points. Flagella may be involved in the maturation of C. difficile 
biofilms, as seen for other bacteria such as Pseudomonas sp., where flagella contribute to the 
architecture of mature biofilms (Barken et al., 2008). Studies on the functions of clostridial 
flagella in biofilms need to be performed under conditions of flow, where development and 
maturation of biofilms can be monitored.  
Cell-cell communication is crucial in a complex structure like biofilms where bacteria are in 
strict contact with one another. Quorum sensing (QS) has an important role in bacterial 
biofilm formation (Hammer and Bassler, 2003); (Vendeville et al., 2005). The enzyme LuxS, 
that synthesizes autoinducer-2 (AI-2), is one of the major modulators of QS, and is largely 
conserved across bacterial species (Hardie and Heurlier, 2008). It was demonstrated that C. 
difficile genome carries a 453-bp gene that encodes a protein which shares 40% identity to the 
V. harveyi LuxS protein, and is responsible for autoinducer-2 (AI-2) production (Carter et al., 
2005). Al-2 is one of the major modulators of quorum sensing and has an important role in 
bacterial biofilm formation (Vendeville et al., 2005); (Hammer and Bassler, 2003). The role 
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of luxS in toxin production is not clear as there are conflicting reports in the literature (Carter 
et al., 2005); (Lee and Song, 2005). While precise mechanisms by which luxS functions in C. 
difficile is unclear at present, our data suggest a role for putative luxS-encoded molecules in 
formation of biofilms in vitro, and may indicate that a luxS-mediated quorum sensing system 
exists in C. difficile. Further work needs to be done to clarify the mechanisms involved in the 
luxS mediated control of biofilm formation. 
Interestingly, we find that a mutant lacking SleC, a protein recently reported to be specifically 
involved in germination of C. difficile spores (Burns et al., 2010), is defective for biofilm 
formation. A role for spore germination in biofilms has not been well studied, however in our 
conditions given the lack of spores, it is unlikely that SleC is involved in germination of 
spores. Given that the sleC mutant biofilms shows strikingly different cellular morphologies, 
it is possible that SleC has other functions such as in hydrolysis of vegetative cell 
peptidoglycans.   
All the mutants were genetically complemented either episomally or chromosomally, and 
biofilm formation was completely or partly restored. 
 
Biofilm formation is a complex process, evolving many different pathways and controlled by 
several regulators. In the model organism in Gram positive bacteria, Bacillus subtilis, four 
different subnetworks are described (Figure 11) (Vlamakis et al., 2013). One of main and best 
described pathways is regulated by master regulator Spo0A, regulator which controls the 
process of sporulation, a critical pathway in bacterial responses to environmental stresses. The 
main regulator that controls entry into sporulation, Spo0A, is well conserved in Bacillus and 
Clostridium species (Lopez and Kolter, 2010); (Underwood et al., 2009). In addition to 
control of entry into sporulation, Spo0A controls a range of other regulatory factors, including 
pathways unrelated to sporulation (Molle et al., 2003). Sporulation and biofilm formation 
have been linked in other bacteria, particularly in Bacillus subtilis. Among more than 100 
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genes that are regulated by Spo0A are genes involved in biofilm matrix expression (Vlamakis 
et al., 2013). Biofilm environments have been shown to be optimal for spore formation and 
spores are part of biofilms for many spore-forming bacteria under nutrient-starved conditions 
(Abee et al., 2011). However, we find extremely low numbers of spores in biofilms (adherent 
and planktonic phases of biofilms) under our conditions. Previously was  demonstrated that a 
B. subtilis spo0A mutant was defective for biofilm formation (Hamon and Lazazzera, 2001), 
and similar to our observation, they did not detect spores in B. subtilis biofilms in vitro 
(Hamon and Lazazzera, 2001). In the case of B. subtilis the switch between biofilm formation 
and sporulation depends on the concentration of phosphorylated Spo0A (Spo0A~P). 
Intermediate levels of Spo0A~P induce expression of genes for biofilm matrix formation, 
while high levels induce sporulation in the cell. Initial phosphorylation induces biofilm 
formation as result of matrix gene expression; once biofilm matures Spo0A~P accumulates in 
some cells and activates sporulation (Vlamakis et al., 2013).  
Our data, and recent data reported by Dawson et al., demonstrate the importance of spo0A for 
biofilm formation by C. difficile (Đapa et al., 2013); (Dawson et al., 2012). Under our in vitro 
conditions, where biofilms are not mature, we detected very low number of spores. Yet, we 
have defective biofilm formation for a spo0A mutant. Our data indicate that the lack of spo0A 
may result in decreased adhesion to surfaces in early stages of biofilm formation. Spo0A has 
also been previously implicated in toxin production in C. difficile, although the exact 
relationship between the two is currently unclear (Underwood et al., 2009); (Deakin et al., 
2012). Thus, spo0A appears to control multiple stress-induced pathways in C. difficile. We 
hypothesize that this regulator may act as a switch between different pathways such as 
sporulation, biofilm formation, and toxin production, selectively inducing one or more of 
these pathways, depending on the local environment. Our observation that bacteria sporulate 
during tube culture but not in biofilms, when incubated under same conditions, may support 
this hypothesis. Recently spo0A mutants were shown to be defective in persistence and 
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transmission in a murine infection model, primarily due to the inability of the spo0A mutant 
strain to form spores (Deakin et al., 2012). In addition to production of spores, the formation 
of biofilms in vivo may also account for the persistence defects observed for the spo0A strain. 
Indeed, during infection, C. difficile spores may be a major part of mature biofilms, where 
spores form as a response to nutrient starvation, as seen in other bacteria (Piggot, 1996). 
Examining the spo0A regulon in C. difficile under different stress conditions could provide 
valuable information about the role/s of this regulator in C. difficile physiology. Moreover, 
how the switch between the biofilm formation and sporulation works in case of C. difficile 
would be interesting to study, preferably by employing mutants in kinases, which are 
responsible for phosphorylation of Spo0A, or by study potential targets, that are affected by 
the concentration of Spo0A~P present in the cell. Employing isogenic mutants, that are 
defective in sporulation, but not in biofilm formation in vivo, and vice versa, would clarify the 
role and the importance two different pathways have for the persistence of the CDI.  
The biofilm defect of the spo0A mutant was partly restored by low inhibitory concentrations 
of antibiotic vancomycin. This suggests that, as it is in B. subtilis, Spo0A-independent 
pathways, which regulate biofilm formation, may exist in C. difficile. In case of B. subtilis 
different enviromental stimuli, e.g. cell wall stress and specific antibiotics stresses, can 
activate several extracytoplasmic function (ECF) RNA polymerase σ-factors, including σM, 
σW and σX (Helmann, 2002). Transcription of Abh, which can indirectly repress the repressor 
SinR, is under the control of σM, σW and σX. Repression of SinR leads to the transcription of 
biofilm matrix genes. As there are no known orthologs for any of this genes in C. difficile, a 
possible way to study the Spo0A-independent biofilm pathway, and the regulation of biofilm 
formation in general, would be to preform a transcriptome analysis on mutant spo0A induced 
with inhibitory concentrations of antibiotic vancomycin. This would give as new insights in 
the regulation of biofilm formation in C. difficile. 
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A Single Nucleotide Polymorphism (SNP) is a DNA sequence variation, which occurs when a 
single nucleotide in the genome is different between members of same biological species. 
SNPs are the most common type of genetic variations. SNPs, insertion and deletion of a single 
nucleotide are called point mutations. SNPs occurring in a DNA sequence, which encodes a 
protein, might result either in a synonymous (silent) codon mutation (no change in the 
encoded amino acid), or in a nonsynonymous mutation (an amino acid change, and has an 
impact on the function of the encoded protein). Point mutations are referred to as the raw 
material of evolution. Presence of a point mutation may provide selective advantage, or 
disadvantage, against other individuals of the same biological species.  
Whole-genome sequencing offers us an efficient approach to associate genotype with 
phenotype. Renzoni et al. used whole-genome sequencing to identify SNPs in two isogenic 
strains of Staphylococcus aureus (Renzoni et al., 2011). A parental strain and a derivative 
strain, which had undergone an in vitro selection for resistance to antibiotic teicoplanin. 
Whole genome sequences showed presence of only three SNPs (in the genes stp1, yjbH and 
vraS). All three SNPs were shown to be required for the highest level of glyopeptide 
resistance (Renzoni et al., 2011). In another study SNPs were connected with rifampicin 
resistance in Mycobacterium tuberculosis (Comas et al., 2012).  
Many contradictions are known in Clostridium difficile literature. The most apparent are two 
studies, published by Nature, which attribute different roles to two main C. difficile toxins, 
ToxA and ToxB. Lyras and co-authors claim that only toxin B is essential for the 
pathogenesis of C. difficile (Lyras et al., 2009), while Kuehne and co-authors found that toxin 
A and toxin B are both needed for the pathogenesis of C. difficile (Kuehne et al., 2010). 
Moreover, the role of Spo0A (Underwood et al., 2009); (Deakin et al., 2012) and luxS (Carter 
et al., 2005); (Lee and Song, 2005) in toxin production remains to be understood, as there are 
conflicting reports in the literature.  
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In our studies we found that clinical C. difficile strains, originally coming from the same out-
break, but stored in different laboratories around United Kingdom, showed differences in 
biofilm formation, sporulation, minimal inhibitory concentration to the antibiotic vancomycin, 
and motility. In collaboration with the Minton laboratory, Clostridia research group (CRG), 
University of Nottingham, whole genome sequencing was performed for two strains of 
R20291, originally from different laboratories. Sequences of these strains showed the 
presence of single nucleotide polymorphisms (SNPs) in different regulatory genes, as 
compared to the published genome sequence. Further to this study, genome sequencing of 
alternate R20291 strains from other laboratories in the Minton Laboratory has also revealed 
SNPs in other genes (unpublished data). The strain, in which we performed our previous 
studies, carries a SNP in anti-sigma factor RsbW and in the gene vncR. Nucleotide in the 
position 245 in gene rsbW changed from a nucleotide ‘G’ to a nucleotide ‘T’, compared to a 
reference genome R20291. The SNP in the genome caused a change in amino acid sequence, 
changing a glycine to valine.  
RsbW is an anti-sigma factor which regulates the stress response induced by alternative sigma 
factor (σB), and its role in biofilm formation was previously shown in other bacteria, e.g. 
Staphylococcus epidermidis (Knobloch et al., 2004). σ-factor B initiates the transcription in 
bacteria by associating with the RNA polymerase core enzyme. Binding of σ-factors to the 
promotors results in a change in the pattern of gene expression. σ-factor B in B. subtilis is 
stimulated by numerous environmental stresses, e.g. signals of energy stress like carbon, 
phosphate or oxygen starvation, and salt, heat, acid, or ethanol shock stresses (Hecker et al., 
1996). The activity of σ-factor B is controlled by a RsbVW partner-switching. RsbVW 
partner-switching is highly conserved among gram positive bacteria that contain σ-factor B 
operon (de Been et al., 2011). In normal conditions σ-factor B is in an inactive state, forming 
a complex with the anti-sigma factor RsbW. When stress conditions occurs, the release of σ-
factor B from RsbW is accomplished by anti-anti σ-factor RsbV, which upon 
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dephosphorylation, sequesters RsbW. Anti σ-factor RsbW in addition acts as a kinase of 
RsbV, providing a negative feedback on activation of σ-factor B. RsbV is dephosphorylated 
during stress conditions, sequestring in this way RsbW, and activating σ-factor B (Hecker et 
al., 2007). In case of S. epidermidis, σ-factor B controls the transcription of genes responsible 
for biofilm formation, and the lack of active anti-sigma factor RsbW results in constantly 
activated σ-factor B  and in increase of biofilm production.  
In our studies, a strain with a deleted rsbW, R20291ΔrsbW, and the gene with a SNP in rsbW, 
R20291_SNP, form significantly more biofilm comparing to the wild-type strain R20291. 
Furthermore, mutants in rsbW form significantly lesser spores (counted by germination of 
heat treated cultures) in biofilm culture and in planktonic growth. Similar results are expected 
when low concentration of Spo0A~P are present in the bacterial cells in case of B. subtilis, 
biofilm formation is induced, and sporulation is repressed. Indeed while we do not know the 
mechanism of action of Spo0A in C. difficile, nevertheless, given the similarities to the 
Bacillus sporulation pathways, we suppose that Spo0A activity is modulated by 
phosphorylation. We hypothesise that σ-factor B indirectly controls biofilm formation by 
repressing transcription of kinases, which would result in low concentrations of Spo0A~P 
present in the cell, or directly, by stimulating the transcription of still unknown genes 
involved in biofilm matrix production.  
Mutants in the gene rsbW, strains R20291ΔrsbW and R20291_SNP, showed few differences 
in growth, and many similarities, e.g. biofilm formation, sporulation and motility. Although 
our attempts to episomally complement the rsbW mutants failed due to potential toxicity of 
the overexpressed regulator in the mutant strains, our results indicate that rsbW is a key 
regulator for biofilm formation and sporulation, and suggest the 245bp-SNP in rsbW gene 
could result in loss of function of rsbW. 
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The human large intestine represents a huge variety of bacterial species, constituting an 
extremely complex and metabolically active site (Probert and Gibson, 2002). Most studies on 
the colonic microbiota have been done on planktonic bacteria found in faeces, but the sessile 
bacteria that form biofilms in the mucus layer of the gut, are likely to play a fundamental role 
in gut health and disease (Croucher et al., 1983). Biofilms formed by anaerobic bacteria from 
the human intestinal tract have been poorly characterized. One of the reasons for this is 
perhaps the difficulties associated with cultivation and standardizing conditions for biofilm 
formation in vitro. Recently the ability to form mono- and duo- species biofilms for several 
gut bacteria such as Bacteroides oralis, various Clostridium species including C. difficile, 
Finegoldia magna, and Fusobacterium necrophorum was shown in vitro (Donelli et al., 2012). 
C. difficile colonization of the gut and mechanisms involved in this process in vivo are poorly 
understood, but it is likely that formation of large microcolonies or biofilm communities have 
a key role in gut colonization and bacterial survival. It is also possible that microcolony 
formation precedes toxin production and modulates spore formation in the colon. Formation 
of bacterial mats has been reported previously in murine C. difficile infections (Lawley et al., 
2009). Such biofilm or multicellular structures could potentially protect bacterium from 
cellular immune responses, invoked by toxin production, and from antibiotics used for the 
treatment of CDI. In addition to spores, which have been linked with persistence of clostridial 
disease (Lawley et al., 2009); (Deakin et al., 2012), biofilm formation in vivo could be another 
factor contributing to the complexities of treatment of CDI, and could explain recurrence of 
clostridial infections. Investigating biofilm development by C. difficile, particularly during 
infection in vivo, is therefore essential for a better understanding of clostridial pathogenesis. 
Screening for inhibitors or designing vaccines against proteins crucial for biofilm 
development could provide effective solutions for treatment or prophylaxis of CDI.  
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Based on our results, we have summarized the roles of C. difficile factors in a hypothetical 
model of biofilm development (Figure 38) (Dapa and Unnikrishnan, 2013). Mechanistic 
studies on how these different proteins mediate biofilm formation, and how their functions are 
coordinated, will shed more light on this complex process. 
 
 
Figure 38 A hypothetical model for C. difficile biofilm development. Bacteria first recognize specific or 
nonspecific attachment sites on an appropriate surface and adhere to it. An intact S-layer and/or adhesins are 
important for this initial step of biofilm formation. Quorum sensing mediated by luxS is crucial during the early 
and late maturation phases, when the cells start to produce a biofilm matrix composed of proteins, extracellular 
DNA and polysaccharides. C. difficile flagella have a role in maturation of biofilms and perhaps in the early 
steps, in directing bacteria to the right attachment sites. Spores are part of C. difficile biofilms, although numbers 
of spores may be maximal in mature biofilms where conditions of nutrient stress are likely. C. difficile biofilms 
can protect bacteria within from the antibiotic vancomycin, although at low concentrations (sub-inhibitory and 
inhibitory concentrations) biofilm formation is induced. The regulator of sporulation, Spo0A controls the step of 
adhesion-aggregation, likely by upregulating expression of adhesins or biofilm matrix genes. Sigma factor B, 
which is controlled by the anti sigma factor B, rsbW, could control biofilm formation indirectly, by regulating 
activity of kinases, or directly, controlling expression of biofilm matrix genes (Modified from Dapa and 
Unnikrishnan, 2013).   
? 
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5 CONCLUSIONS 
In conclusion, we demonstrate that clinically relevant strains of the anaerobic gut pathogen 
Clostridium difficile are able to form complex biofilms in vitro. C. difficile biofilm formation 
appears to be a multifactorial process with a role for proteins that are important in different 
aspects of bacterial physiology. Indeed, the details of the precise roles of each of these 
proteins/pathways and their regulation remain to be studied. A possible model of infection is 
that C. difficile colonizes the colon via formation of microcolonies or biofilms, followed by 
toxin production. Formation of biofilms in vivo perhaps provides the bacterium with a 
mechanism to protect itself from the cellular immune responses invoked by the toxins, in 
addition to a mechanism of persistence in presence of antibiotics. Investigation of C. difficile 
biofilm development during infection and factors controlling it could give us a better insight 
into their role in C. difficile pathogenesis. 
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APPENDIX 
APPENDIX 1 – Growth media  
 
BHIS 
 
BHI  37 g/l  
Yeast extract  5 g/l  
L-cysteine  1 g/l  
ddH2O  
 
15 g/l agar is added to have a solid medium. The medium is sterilized in autoclave and stored 
at 4°C. 
 
 
LB  
 
Tryptone peptone  10 g/l  
Yeast extract  5 g/l  
NaCl  10 g/l  
dH2O  
 
The pH is adjusted to 7.6, then the medium is sterilized in autoclave and stored at 4°C.  
15 g/l agar are added to have a solid medium. 
 
 
TYM 
 
Tryptone peptone (Difco)  24 g/l  
Yeast extract  12 g/l  
Mannitol  10 g/l  
Glycerol  1 g/l  
ddH2O  
 
The pH is adjusted to 6.8. The medium is sterilized in autoclave and stored at 4°C. 
 
 
CDMM-Clostridium difficile Minimal medium  
 
Aminoacids: 
L-cysteine  0.5 g/l  
L-isoleucine  0.1 g/l  
L-leucine  1.0 g/l  
L-proline  0.8 g/l  
L-tryptophan  0.1 g/l  
L-valine  0.1 g/l  
L-arginine  0.1 g/l  
Glycine  0.1 g/l  
L-histidine  0.1 g/l  
L-methionine  0.1 g/l  
L-threonine  0.1 g/l  
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Salts: 
KH2PO4  0.3 g/l  
Na2HPO4  1.5 g/l  
NaCl  0.9 g/l  
CaCl2∙2H2O  26 mg/l  
MgCl2∙6H2O  20 mg/l  
MnCl2∙4H2O  10 mg/l  
(NH4)2SO4  0.44 g/l  
FeSO4∙7H2O  4 mg/l  
NaHCO3  5 g/l  
 
Vitamins: 
Biotin  10 μg/l  
Calcium pantothenate  1 mg/l  
Pyridoxine hydrochloride  100 μg/l  
 
Powders are dissolved in ddH2O. The pH is adjusted to 7.4. The medium is filter sterilized 
and stored at 4°C. 
 
 
CDM - MINIMAL MEDIUM FOR SELECTION OF DOUBLE CROSS-OVER 
CLONES  
 
To make 100 ml Minimal medium: 
 
Sterile anaerobic ddH2O 61 ml 
Amino acid solution (5X) 20 ml 
Salt solution (10X)                  10 ml 
20% glucose solution 5 ml 
Trace salt solution (50X) 2 ml 
FeSO4∙7H2O solution (100X) 1 ml 
Vitamin solution (100X) 1 ml 
 
Amino acid solution (5X): 
Dissolve the following quantities in 200 ml of ddH2O: 
 
Cas-amino acids 10.0 g 
L-Tryptophan 0.5 g 
L-Cysteine 0.5 g 
 
Salt solution (10X):  
Dissolve the following quantities in 200 ml of ddH2O: 
 
KH2PO4  1.8 g  
NaCl  1.8 g  
Na2HPO4  10.0 g  
NaHCO3  10.0 g  
dH2O  
 
Glucose solution:  
20% w/v glucose 
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Trace salt solution (50X):  
Dissolve the following quantities in 200 ml of ddH2O: 
 
CaCl2∙2H2O  260 mg  
MnCl2∙4H2O  100 mg  
MgCl2∙6H2O  200 mg  
(NH4)2SO4  400 mg  
 
 
FeSO4∙7H2O solution (100X):  
Dissolve 20 mg FeSO4∙7H2O in 50 ml anaerobic water 
 
Vitamin solution (100X):  
Dissolve each of the following vitamins in 200 ml of water: 
 
Ca-D-panthotenate  20 mg  
Pyridoxine  20 mg  
d-biotin  20 mg  
 
The medium is filter sterilized and stored at 4°C. 
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APPENDIX 2 – Bacterial strains and plasmids 
 
 
Strain or plasmid Relevant properties Source or reference  
E. coli CA434 Conjugation donor (Purdy et al., 2002) 
CdiR20291Δcwp84 
(Δcwp84) 
C. difficile R20291 strain with 
an in frame deletion of cwp84 
from 642-bp to 1887-bp  
(Ng et al., 2013)  
CRG3351(fliC) CdiR20291-fliC430s::CT  (Baban et al., 2013) 
CRG1183 (luxS) CdiR20291-luxS161a::CT  (Đapa et al., 2013) 
CRG1166 (sleC) CdiR20291-sleC128a::CT   (Burns et al., 2010) 
CRG1375 (spo0A) CdiR20291-spo0A178a    (Heap et al., 2010) 
CdiR20291Δcwp84-C 
(Δcwp84-C) 
C. difficile R20291 Δcwp84 
complemented with cwp84 on 
the chromosome 
(Ng et al., 2013) 
CRG1183-C (luxS-C) CRG1183 containing pMTL-
TD1  
(Đapa et al., 2013) 
CRG1634 (sleC-C) CRG1166  containing pMTL-
DB1  
(Burns et al., 2010) 
CRG3359 (fliC-C) CRG3351 mutant containing 
pMTLSB1 
(Baban et al., 2013) 
CRG1375-C (spo0A-C) CRG1375 containing 
pMTL960:spo0A(Cdi) 
(Đapa et al., 2013) 
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CdiR20291ΔrsbW (ΔrsbW) C. difficile R20291 strain with 
an in frame deletion of rsbW 
from 10-bp to 401-bp 
This study 
Plasmids Relevant properties Source or reference 
pMTL84151 Clostridium modular plasmid 
containing catP 
(Heap et al., 2009) 
pMTL-DB1 pMTL84151 containing 1,272-
bp sleC coding region and 
244-bp upstream promoter 
region 
(Burns et al., 2010) 
pMTL-TD1 pMTL84151 containing 456-
bp luxS coding region and 124-
bp upstream promoter region 
(Đapa et al., 2013) 
pMTLSB1 pMTL84151 containing 873-
bp fliC coding region and 100-
bp upstream fliC promotor 
region 
(Baban et al., 2013) 
pMTL960:spo0A(Cdi) pMTL-960 containing spo0A 
open reading frame with 174-
bp of upstream sequence and 
205-bp of downstream 
sequence 
(Đapa et al., 2013) 
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APPENDIX 3 – Primers 
 
F1_rsbW TTTTTTGTTTAAACTAAACAGCATAAATAAGGTTGT  
                    PmeI 
 
R1_rsbW GGGCTAGAATTCGTAATTTCCATCTTTATAGTCT     
                   EcoRI 
 
F2_rsbW GGGCTAGAATTCAATGACTAAATATTTAGGAGTTGA   
                   EcoRI 
 
R2_rsbW TTTTTTGTTTAAACTTGATATCCATAAGAAGCCTCC  
                    PmeI 
 
SC7_F GACGGATTTCACATTTGCCGTTTTGTAAACGAATTGCAGG 
 
SC7_R AGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGG 
 
Rsb_contr_F TAGTAGGAAGCTCTGCTCTTATAGTAGC 
 
Rsb_contr_R AATCTTCATACTCTATACTTCCAAAGTTACC 
 
luxS_95_F AGTAACTAAATTTGACTTGAGATTTTTACAGCC 
 
luxS_262_R AACCAATCTTAACTGTTTTGGCATCTACATCTCCCC 
 
F1_luxS TAAAGAATGCGGCCGCGTACGATTATGTGATATAAATATTATAAC 
                          NotI                               
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R1_luxS TAAAGAATCTCGAGTTATTCTCCATATATATTTAAAGAAAATCC 
                          XhoI   
 
Cdi-spo0A-F1 AACTAGTGGTATTTTTATAGATGAAATGATAAAATTGTAGGTGAG  
   SpeI 
 
Cdi-spo0A-R1 GGATCCTCAGTTTACAACTTGTAAAGACA CATACTATATCC 
  BamHI 
 
rsbW_F TTTGGAATGTTTGTCTTGATGG 
 
rsbW_R GCTAACAATCTTGCTAAATACAGATG 
 
 
 
 
 
 
